The QualityStocks Daily Tuesday, April 16th, 2019

Today's Top 3 Investment Newsletters

AwesomeStocks (VPOR) +50.00%

QualityStocks (MAGE) +35.40%

StreetInsider (JMIA) +34.88%

The QualityStocks Daily Stock List

Repro Med Systems, Inc. (REPR)

Stockrow, Zacks, Business Wire, AIStockFinder, Capital Cube, InvestorsHub, Streetwise Reports, Wallet Investor, Simply Wall St, Wallmine, Dividend Investor, Infront Analytics, Stockopedia, Equity Clock, 4-Traders, Accesswire, MarketWatch, Stockhouse Market Screener, Real Investment Advice, and Marketbeat reported previously on Repro Med Systems, Inc. (REPR), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

Incorporated in 1980, Repro Med Systems, Inc. does business as RMS Medical Products. RMS develops, manufactures and commercializes medical products used for home infusions. The Company's mission is to improve the quality of life of patients globally via the development and delivery of high quality, unique and easy to use therapeutic solutions. Repro Med Systems lists on the OTC Markets' OTCQX. The Company is based in Chester, New York.

RMS' main products are the FREEDOM60® and FreedomEdge® DynEQ Infusion Systems, RMS Precision Flow Rate Tubing™, HIgH-Flo Subcutaneous Safety Needle Sets™ and RES-Q-VAC® Hand Held Medical Suction. At present, the FREEDOM Syringe Infusion System includes the FREEDOM60® and FreedomEdge® Syringe Infusion Drivers, RMS Precision Flow Rate Tubing™ and RMS HIgH-Flo Subcutaneous Safety Needle Sets™.

These devices are used for infusions administered in professional healthcare settings and also at home. RMS Medical Products also provides education and training materials to clinicians, patients, and patient advocates. The Company's products, and product support, are offered around the world by RMS and via an international network of distributors and service providers.

RMS Medical Products specializes in developing and manufacturing portable medical devices and supplies that are safe and affordable, for a broad array of markets. These include hospitals, home healthcare, nursing homes and rescue services. The Company's products do not rely on batteries or electric power. Therefore, this makes them dependable in critical situations.

Recently, Repro Med Systems, Inc. dba RMS Medical Products announced the latest financial results for the three and twelve months ending December 31, 2018 and outlined its plans for continued strong growth. The Company reported record 2018 Revenue of $17.4 million. This is up 12.4 percent versus 2017. It had improved 2018 Profitability; improved Gross Margin, record Net Income and Adjusted EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization). The Strategic Plan was adopted with goals of $50 million Net Revenues, 70 percent+ Gross Margins and 20 percent+ annual organic Revenue growth through 2022.

The Company also recently announced that Brian Schiller, PhD, was hired as the Vice President of Medical Affairs. Mr. Don Pettigrew, President and Chief Executive Officer of RMS Medical, said, ''Dr. Schiller is a proven leader within the pharmaceutical medical affairs and clinical research space. His past experience will allow him to excel at RMS Medical while we pursue deeper relationships with potential pharmaceutical partners to expand our market opportunity; a key component of our growth plans.''

Repro Med Systems, Inc. (REPR), closed Tuesday's trading session at $1.44, down 1.37%, on 38,677 volume with 33 trades. The average volume for the last 3 months is 21,524 and the stock's 52-week low/high is $1.10/$1.79.

chart

PeerStream, Inc. (PEER)

Stock Twits, Zacks, Stockwatch, Barchart, GlobeNewswire, Real Investment Advice, Wallet Investor, Simply Wall St, Morningstar, Last10k, Dividend Investor, Stockopedia, YCharts, 4-Traders, Street Insider, OTC Markets, Market Screener, Marketbeat, InvestorsHub, Proactive Investors, and MarketWatch reported beforehand on PeerStream, Inc. (PEER), and today we are reporting on the Company, here at the QualityStocks Daily Newsletter.

PeerStream, Inc. builds decentralized technologies for multimedia social apps and business communication solutions globally. It is a communications software innovator developing enhanced security and privacy solutions for video, voice, and text applications and data transmission. PeerStream holds 26 patents. The Company previously went by the name Snap Interactive, Inc. It changed its name to PeerStream, Inc. in March of 2018. The Company is based in New York, New York and lists on the OTCQB.

PeerStream's offerings target consumer, government, as well as enterprise clients. The Company uses multi-layered encryption, blockchain technology and other recent innovations. It is developing its proprietary PeerStream Protocol (PSP) to offer clients first-rate data security and confidentiality over distributed or decentralized networks.

In addition, the Company launched its Backchannel product suite in private beta. This includes cross platform applications, middleware and software development kits (SDKs) designed to offer a highly secure end user communication experience when coupled with PSP. For two decades, PeerStream has built and continues to operate unique consumer applications. These include Paltalk and Camfrog, which are two of the largest live video social communities.

Last month, ElevenPaths, Telefónica's Cybersecurity Unit, and Rivetz, an industry leader in decentralized hardware-based cybersecurity, announced that PeerStream will join its partnership to offer next-generation zero trust architecture, privacy and security protection for enterprise applications and communications. PeerStream is driving adoption of emerging blockchain technologies.

PeerStream is developing enterprise-grade communications software centering on enhanced privacy and security that it is planning to bring to market under the Backchannel brand. The design of Backchannel is to offer a growing set of software tools built to power secure, real-time data and messaging channels, which are also planned to support streaming video.

At the heart of Backchannel is PeerStream's decentralized network routing technology, PeerStream Protocol (PSP), which may operate on either blockchain or traditional distributed architectures. The parties plan to integrate Backchannel with the Dual Roots of Trust advanced cybersecurity architecture developed by Rivetz and ElevenPaths.

In March, PeerStream announced financial and operational results for Q4 and year ended December 31, 2018. Financial highlights for 2018 include Total Revenues increasing to $26.4 million. This represents 6.1 percent growth versus the year ended December 31, 2017. This was driven mainly by Revenue generated under the technology services agreement with ProximaX Limited.

Net Loss was roughly $3.8 million for the year ended December 31, 2018. This represents a $2.1 million improvement versus a Net Loss of roughly $5.9 million for the year ended December 31, 2017. The 2018 Net Loss was mainly because of a non-cash $2.5 million impairment loss on digital tokens received by PeerStream in connection with the ProximaX technology services agreement.

PeerStream, Inc. (PEER), closed Tuesday's trading session at $3.00, even for the day, on 2,020 volume with 10 trades. The average volume for the last 3 months is 303 and the stock's 52-week low/high is $1.05/$7.50.

chart

Magellan Gold Corporation (MAGE)

Wallet Investor, Simply Wall St, Mining Capital, Street Insider, YCharts, InvestorsHub, The Street, Canadian Insider, Market Screener, Investors Hangout, Proactive Investors, Tmxmoney, Mining Clips, Barchart, Stockhouse, and PR Newswire reported on Magellan Gold Corporation (MAGE), and we highlight the Company as well, here at the QualityStocks Daily Newsletter.

OTCQB-listed, Magellan Gold Corporation concentrates on the exploration and development of precious metals. In November of 2017, the Company completed the purchase of the SDA Mill in the State of Nayarit, Mexico. Furthermore, in August of last year, it announced the acquisition of the close by El Dorado Gold-Silver Project. In addition, Magellan Gold owns an advanced silver exploration project in Arizona. The Company is headquartered in Reno, Nevada.

The SDA Mill is a fully operational flotation plant. It additionally includes a precious metals leach circuit and associated assets, licenses and agreements. The mill has a ten-year operating history, processing ore at a rate of 100 tons per day. Historically its operation has been founded on sales of flotation concentrates to smelters, and payment for precious metals content. The mill lies within the rich Sierra Madre Occidental mineralized belt.

The El Dorado Gold-Silver Project comprises a 50-hectare mining concession that is 50 kilometers south of the SDA Mill. El Dorado is within a district of epithermal vein systems from which historic mining produced high grades. Drilling in 2010-2011 identified gold-silver resources on two veins that hold promise for underground mining. Upon completion of permitting and obtaining financing, Magellan Gold's intention is to start mining at a production rate of 100 tons per day.

Last month, Magellan Gold announced that it engaged the services of senior mining consultant, Mr. David E. Drips, to provide guidance in the evaluation, design and development of Magellan's El Dorado Gold-Silver mining project. The Company has continued to advance El Dorado, which lies 50 kilometers south of the Company's SDA Mill. Magellan Gold plans to process the ore at the SDA Mill once the new mine is developed.

This month, Magellan Gold provided an update on its El Dorado Gold-Silver Mine and its SDA Mill in Nayarit State, Mexico. In March, Magellan gained the support of the local permitting officials. The Company anticipates the new federal administration will favor the permitting of El Dorado, including both environmental and explosives permits, allowing the mine's economic impact to improve the local community. Magellan Gold anticipates receiving both of these important permits later this year and then could be in a position to move ahead with mine development.

Magellan Gold has launched a regional program with a senior Mexican geologist to locate other sources of ore to feed the SDA Mill. The goal is to use the mill to produce revenue and defray holding costs until El Dorado reaches production.

Magellan Gold Corporation (MAGE), closed Tuesday's trading session at $2.18, up 35.40%, on 3,100 volume with 7 trades. The average volume for the last 3 months is 2,587 and the stock's 52-week low/high is $0.60/$3.79.

chart

Dyadic International, Inc. (DYAI)

Proactive Investors, Marketbeat, Market Screener, Wallmine, OTC Markets, Value Investors Club, Investors Hub, Zacks, Stockhouse, Equity Clock, Wallet Investor, Stockopedia, Uptick Newswire, and GuruFocus reported earlier on Dyadic International, Inc. (DYAI), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

Dyadic International, Inc. is an international biotechnology company based in Jupiter, Florida. It focuses on further improving and applying its proprietary C1 gene expression platform. The Company is developing what it believes will be a potentially significant biopharmaceutical gene expression platform founded on the fungus Myceliophthora thermophila, called C1.

The C1 microorganism enables the development and large scale manufacture of low cost proteins. It has the potential to be further developed into a safe and efficient expression system, which may help accelerate the development, lower production costs and improve the performance of biologic vaccines and drugs at flexible commercial scales.

Dyadic International is using the C1 technology and other technologies to conduct research, development and commercial activities for the development and manufacturing of human and animal vaccines and drugs (including virus like particles (VLPs) and antigens), monoclonal antibodies, Fab antibody fragments, Fc-Fusion proteins, biosimilars and/or biobetters, and other therapeutic proteins.

Furthermore, the Company more recently is also starting to explore the use of its C1 technology and other technologies to conduct research, development and commercial activities for the development and manufacturing of Adeno-associated viral vectors (AAV) and certain metabolites.

Recently, Dyadic International announced its financial results for the year ended December 31, 2018, and recent developments. The Company had nine funded proof of concept research collaborations signed in 2018 and two new collaborations in 2019. Improved scientific data was generated. This reflects strong C1 capabilities and new attributes. Research and development Revenue for the year ended December 31, 2018, increased to roughly $1,295,000 versus $758,000 for the year ended December 31, 2017.

Mr. Mark Emalfarb, Dyadic International's Chief Executive Officer, said, "2018 was another year of continued progress with many favorable milestones. I am very pleased to report that we have signed nine funded research collaborations in 2018, including Sanofi-Aventis, and Mitsubishi Tanabe Pharma, which we previously announced, a collaboration with a top twenty pharmaceutical company in Q4 2018. In the first quarter of 2019, we signed two new research collaboration agreements both with top twenty-five pharmaceutical companies. These programs demonstrate that the market and the industry are taking notice of Dyadic and the perceived capability of our C1 gene expression platform."

Yesterday, Dyadic International announced that its common stock was approved to list on The Nasdaq Capital Market. The expectation is that trading on the Nasdaq will begin on or about April 17, 2019 under the trading symbol DYAI.

Dyadic International, Inc. (DYAI), closed Tuesday's trading session at $3.50, down 1.62%, on 78,599 volume with 179 trades. The average volume for the last 3 months is 54,950 and the stock's 52-week low/high is $1.39/$3.85.

chart

Gulf Keystone Petroleum Limited (GUKYF)

Small Cap Network, 4-Traders, Investing Online, Trading View, Real Investment Advice, Equity Clock, Market Screener, MarketWatch, Wallmine, Dividend Investor, Whale Wisdom, Value Forum, The Street, Wallet Investor, and Stockhouse reported earlier on Gulf Keystone Petroleum Limited (GUKYF), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

Incorporated in Bermuda in 2001, Gulf Keystone Petroleum Limited is a foremost independent operator and producer in the Kurdistan Region of Iraq. The Company is the operator of the Shaikan oil field with present production capacity of 40,000 barrels of oil per day. In 2009, Gulf Keystone Petroleum discovered the Shaikan field. The Company also provides geological, geophysical, and engineering services. Gulf Keystone Petroleum lists on the OTC Markets Group's OTCQX. The Company has its corporate office in Hamilton, Bermuda. It has further offices in Erbil, Kurdistan Region of Iraq; and London, United Kingdom (UK).

Gulf Keystone has a first-rate track record of demonstrated drilling and operating successes in the Kurdistan area of Iraq. The Company's strategy is to move to the large-scale staged development of the Shaikan field. Its near-term strategy is to maintain production from Shaikan production facilities at 40,000 bopd, with a view to expanding to 55,000 bopd, and further beyond. The Shaikan block is positioned approximately 60 km to the north-west of Erbil covering an area of 283 km².

Gulf Keystone Petroleum International Ltd. (GKPI), a wholly-owned subsidiary of Gulf Keystone Petroleum Limited, holds an interest in the Shaikan Block Production Sharing Contract (PSC), where it is the operator. On August 6, 2009, Gulf Keystone announced a major discovery with the Shaikan-1 exploration well. It declared Shaikan a commercial discovery in August of 2012. The Shaikan Field Development Plan was approved in June of 2013.

Gulf Keystone Petroleum has been present in the Kurdistan region since 2007. The Company works closely with the Ministry of Natural Resources, one of its partners on the Shaikan field. This is to attain its joint goal of developing the resources for the broader benefit of the region, and all of its stakeholders.

Gulf Keystone Petroleum believes there is significant growth potential for the Shaikan Field. Material oil volumes are in the Cretaceous, Jurassic and Triassic formations. At present, production is from Jurassic only. A staged approach is being undertaken to de-risk field long-term potential.

Gulf Keystone Petroleum Limited (GUKYF), closed Tuesday's trading session at $3.36, even for the day, on 200 volume with 2 trades. The average volume for the last 3 months is 1,512 and the stock's 52-week low/high is $2.05/$3.98.

chart

Ivanhoe Mines Ltd. (IVPAF)

Stock News Union, Stockhouse, MarketWatch, 4-Traders, Wallet Investor, Market Screener, Investors Hangout, Marketbeat, Dividend Investor, Equity Clock, StreetWise Reports, InvestorsHub, Insider Financial, Trading View, YCharts, and Street Insider reported previously on Ivanhoe Mines Ltd. (IVPAF), and today we are reporting on the Company, here at the QualityStocks Daily Newsletter.

Ivanhoe Mines Ltd. engages in the exploration, development, and recovery of minerals and precious metals located mainly in Southern Africa. The Company previously went by the name Ivanplats Limited. It changed its corporate name to Ivanhoe Mines Ltd. in August of 2013. OTCQX-listed, Ivanhoe Mines has its head office in Vancouver, British Columbia.

The Company is centering on advancing its three main projects in Southern Africa: the development of new mines at the Kamoa-Kakula copper discovery in the Democratic Republic of Congo (DRC) and the Platreef palladium-platinum-nickel-copper-gold discovery in South Africa; and the wide-ranging redevelopment and upgrading of the historic Kipushi zinc-copper-germanium-silver mine, also in the DRC.

The Kamoa-Kakula Copper Project - a joint venture (JV) between Ivanhoe Mines (39.6 percent), Zijin Mining Group (39.6 percent), Crystal River Global Limited (0.8 percent) and the Government of the Democratic Republic of Congo (20 percent) - has been independently ranked as the world's largest, undeveloped, high-grade copper discovery by global mining consultant Wood Mackenzie.

Ivanhoe Mines indirectly owns 64 percent of the Platreef Project via its subsidiary, Ivanplats, and is directing all mine development work. The South African beneficiaries of the approved broad-based, black economic empowerment structure have a 26 percent stake in the Platreef Project. The remaining 10 percent is owned by a Japanese consortium of ITOCHU Corporation; Japan Oil, Gas and Metals National Corporation; and Japan Gas Corporation.

The Kipushi Project is a JV between Ivanhoe Mines and the DRC state-owned mining company, La Générale des Carrières et des Mines (Gécamines). In addition, Ivanhoe Mines is exploring for new copper discoveries on its wholly-owned Western Foreland exploration licences. These licenses are adjacent to the Kamoa-Kakula mining licence. Ivanhoe Mines' DRC exploration group is targeting Kamoa-Kakula-style copper mineralization by way of a regional exploration and drilling program on its 100 percent-owned Western Foreland exploration licences.

Recently, Ivanhoe Mines announced that it filed an updated National Instrument 43-101 (NI 43-101) technical report covering the June 2018 Mineral Resource estimate for the Kipushi Project in the DRC. The technical report was independently prepared by OreWin Pty Ltd., The MSA Group (Pty) Ltd., SRK Consulting (South Africa) (Pty) Ltd., and MDM (Technical) Africa Pty Ltd. (a division of Wood PLC).

The technical report titled "Kipushi 2019 Mineral Resource Update" was filed on the SEDAR website at www.sedar.com and on the Ivanhoe Mines website at www.ivanhoemines.com.

Ivanhoe Mines Ltd. (IVPAF), closed Tuesday's trading session at $2.30, down 2.95%, on 45,855 volume with 68 trades. The average volume for the last 3 months is 135,740 and the stock's 52-week low/high is $1.50/$2.77.

chart

School Specialty, Inc. (SCOO)

NetworkNewsWire, Zacks, Simply Wall St, MarketWatch, Wallmine, Stockopedia, Wallet Investor, Seeking Alpha, Marketbeat, YCharts, Stockhouse, Capital Cube and 4-Traders reported earlier on School Specialty, Inc. (SCOO), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

School Specialty, Inc. is a foremost provider of unique products and solutions that support integrated learning environments for improved student social, emotional, mental and physical well-being. The Company designs, develops and delivers the widest array of innovative and proprietary products, programs and services to the education marketplace. This includes essential classroom supplies, furniture, educational technology, supplemental learning resources, science-based curriculum, and evidence-based safety training & security. Founded in 1959 and OTCQB-listed, School Specialty is headquartered in Greenville, Wisconsin.

The Company empowers leaders with modern educational ecosystems that optimize student outcomes. School Specialty creates holistic environments, from crayons to curriculum, furniture to technology. Its products work together to create spaces where students can grow mentally, physically, socially and emotionally.

School Specialty offers its own proprietary products from best-in-class brands like Sax, SSI Guardian, Frey, Foss and School Smart. It also offers some of the most trusted third-party brands in the educational market. The Company has grown into an enterprise that includes more than 70 subject matter experts and other industry thought leaders always seeking out and sharing leading edge ideas to advance modern education.

School Specialty mainly serves the preK-12th grade market. Nonetheless, it has recently expanded its presence in non-traditional channels, including e-commerce and retail. The Company offers its products via two operating groups: Distribution and Curriculum.

This past February, School Specialty announced that its Board of Directors appointed Mr. Michael Buenzow as interim Chief Executive Officer (CEO). Mr. Buenzow succeeds Mr. Joseph Yorio, President and CEO of School Specialty since 2014, who resigned from the Company to pursue other opportunities. Mr. Buenzow began his role effective immediately.

Mr. Buenzow is a proven executive. He has over 25 years of interim management and operational experience, having served as interim CEO for manifold companies including Bush Furniture and Huffy Bicycle. Mr. Buenzow's experience covers several industries. These include furniture, retail and consumer products. Based in Chicago, Mr. Buenzow presently is a Senior Managing Director at FTI Consulting.

Last month, School Specialty provided results for its fiscal Q4 and fiscal year ended December 29, 2018 and its initial outlook for fiscal 2019. Revenue was $673.5 million for the fiscal year ended December 29, 2018, versus $658.4 million in fiscal 2017. This represents an increase of 2.3 percent.

Fiscal Q4 2018 Revenue of $114.6 million was up 1.9 percent versus the previous year period. However, it was roughly 5.4 percent below expectations because of declines in the Science Curriculum category and lower than expected Revenue growth in the Supplies, Furniture and Instruction & Intervention categories.

School Specialty provided the following financial outlook for fiscal 2019: Total Revenue of roughly $705 to $720 million. This represents a 5-7 percent increase year-over-year. The expectation is that Revenue growth will be driven by growth in the Science Curriculum, Furniture, and Supplies categories. The Company expects stable performance in Instruction & Intervention as the integrated sales organization matures and new products are launched. The expectation is that growth in these areas will be partially offset by declines in Agendas and A/V Tech.

School Specialty, Inc. (SCOO), closed Tuesday's trading session at $6.10, up 6.09%, on 6,250 volume with 6 trades. The average volume for the last 3 months is 6,651 and the stock's 52-week low/high is $5.75/$20.02.

chart

QS Energy, Inc. (QSEP)

RedChip, InvestorsHub, Dividend Investor, GuruFocus, last10k, Stockopedia, Equity Clock, Stockhouse, MarketWatch, Marketwired, StockInvest.us, The Street, and Small Cap Exclusive reported earlier on QS Energy, Inc. (QSEP), and today we choose to report on the Company, here at the QualityStocks Daily Newsletter.

Established in 1998, QS Energy, Inc. is a developer of integrated technology solutions for the energy industry. It develops and commercializes energy efficiency technologies that help in meeting rising global energy demands, improving the economics of oil extraction and transport, and lessening greenhouse gas emissions. The Company's Intellectual Property (IP) portfolio includes 48 domestic and worldwide patents and patents pending. These have undergone development in combination with, and exclusively licensed from, Temple University. OTCQB-listed, QS Energy is based in Tomball, Texas.

QS Energy's AOT™ (Applied Oil Technology) is a group of commercial crude oil pipeline flow assurance products designed to undergo installation at pipeline pump stations in the upstream, gathering, and midstream sectors. AOT™ is an integrated system. It improves vital operational efficiencies for pipeline operators worldwide. The Company has its new strategic plan. The core mission of this plan is to expedite market adoption of its AOT™ technology.

AOT™ is an industrial hardware system and is completely fabricated in the U.S. AOT™ lowers the viscosity of unrefined oil utilizing low wattage electrical fields (electrorheology) to improve flow while in transit through pipelines. AOT™ technology delivers performance that can be measured in each of the areas of importance in the movement hydrocarbon stream - from reservoir to the point of sale.

QS Energy's AOT™ stand-alone or supplemental pipeline solutions increase flow rates. The Company's solutions also reduce power consumption; optimize flow assurance; enhance pipeline integrity; and prevent bottlenecks. QS Energy is now positioned to complete its development from research and development (R&D) to commercialization.

This month, QS Energy presented a shareholder update from Mr. Jason Lane, Chief Executive Officer and Chairman of the Board of the Company. Progress is speeding up on QS Energy's AOT demonstration project. The Company states that it is currently in what it hopes will be the final steps towards commercial operations. QS Energy also notes that its AOT demonstration project is in the very capable hands of its pipeline operations partner as they work to complete the AOT installment design, site preparation, as well as installation details.

This has led QS Energy to restructure internal operations and external communications. All engineering, mechanical and logistical functions have been moved to Houston operating out of the Company's headquarters in Tomball, Texas. Moreover, QS Energy has been invited to participate as a premium presenting company in the annual Spring Investor Summit in New York, New York, April 1st and 2nd, 2019.

QS Energy, Inc. (QSEP), closed Tuesday's trading session at $0.285, up 1.79%, on 70,138 volume with 14 trades. The average volume for the last 3 months is 152,956 and the stock's 52-week low/high is $0.061/$0.379.

chart

MannKind Corporation (MNKD)

Stock Market Stop, Simply Wall St, Street Insider, Stockhouse, The Street, Seeking Alpha, Talk Traders, Zacks, Proactive Investors, GlobeNewswire, InvestorsHub, Investor Place, Stock News, MarketWatch, Market Screener, Morningstar, Barchart, and GuruFocus reported earlier on MannKind Corporation (MNKD), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

A biopharmaceutical enterprise, MannKind Corporation concentrates on the development and commercialization of inhaled therapeutic products. These products are for patients with diseases such as pulmonary arterial hypertension and diabetes. In addition, the Company employs field sales and medical representatives throughout the United States. MannKind has its corporate office in Westlake Village, California. It also has a state-of-the art manufacturing facility in Danbury, Connecticut.

MannKind's dry powder formulations are founded on Food and Drug Administration (FDA)-approved excipients. This includes fumaryl diketopiperazine (the excipient used in Technosphere® inhalation powders) and mannitol. The Company's pipeline includes Epinephrine Technosphere® for anaphylaxis; and Treprostinil Technosphere® for Pulmonary Arterial Hypertension (PAH). Additionally, MannKind's pipeline includes Palonosetron Technosphere® for Chemotherapy-Induced Nausea and Vomiting (CINV).  

MannKind is now commercializing Afrezza® (insulin human) inhalation powder. This is its first FDA-approved product. Afrezza® is the only inhaled rapid-acting mealtime insulin in the United States. Afrezza® utilizes the Company's above-mentioned proprietary Technosphere® formulation technology. The basis of this technology is on a class of organic molecules designed to self-assemble into small particles onto which drug molecules can be loaded.

Afrezza® is available in the U.S. by prescription from pharmacies across the country. Afrezza® is a fast-acting inhaled insulin used to improve glycemic control in adults with diabetes. Afrezza® is taken at the start of a meal using the specially designed inhaler. One breath delivers one dose. Afrezza® dissolves quickly upon inhalation to the deep lung. It delivers insulin fast to the bloodstream. Peak insulin levels are attained within 12 to 15 minutes of use and help to control post-meal blood sugar spikes that affect HbA1C levels.

MannKind's inhalers efficiently focus the energy supplied by the patient's breath directly onto the dry powder. This results in high delivery performance. The Company's single-use and reusable inhalers are breath-powered. Therefore, they necessitate only the patient's inhalation effort to deliver the powder.

In January, MannKind announced a direct purchase program to assist those with diabetes obtain the Company's inhaled insulin, Afrezza®, for as little as $4 a day. Furthermore, MannKind has launched an enhanced copay and savings card program. It will enable patients with commercial insurance to fill their prescription at their local pharmacy for as low as $15.

Mr. Michael Castagna, Chief Executive Officer of MannKind, said, "Our new Afrezza Patient Direct Program enables us to streamline the numerous costs and inefficiencies that exist in today's healthcare system, so we can pass along the savings directly for these patients. We want to be part of the solution for the future of healthcare and healthy living."

MannKind Corporation (MNKD), closed Tuesday's trading session at $1.62, even for the day, on 1,578,033 volume with 4,404 trades. The average volume for the last 3 months is 3,086,454 and the stock's 52-week low/high is $0.939/$3.039.

chart

Almost Never Films, Inc. (HLWD)

Street Insider, InvestorsHub, PR Newswire, Ticker Report, Penny Stock Hub, OTC Markets, The Street, YCharts, Barchart, Simply Wall St, Dividend Investor, Street Insider, Market Exclusive, MarketWatch, Marketbeat, and Equity Clock reported beforehand on Almost Never Films, Inc. (HLWD), and we also highlight the Company, here at the QualityStocks Daily Newsletter.

Almost Never Films, Inc. is an independent film company headquartered in Los Angeles, California. The Company's emphasis is on film production, finance and production related services for movies under budgets of $35 million. Its business is to enable relationships between creative talent and companies who produce, finance and distribute motion pictures. Almost Never Films' shares trade on the OTC Markets.

Almost Never Films' goal is to create, acquire, or license rights to materials upon which it believes motion pictures can be based (screenplays, books, short stories, etc.). The Company has a strategic partnership with Pure Flix Entertainment. This partnership is a multi-film financing agreement to produce six faith-based original motion pictures.

Pure Flix Entertainment is a U.S. independent Christian film and television studio, based in Scottsdale, Arizona. Pure Flix Entertainment will distribute the films globally in new media format. Almost Never Films will contribute its financial, development, and production services.

Almost Never Films previously announced the release of its two faith-based films "The Prayer Box" and "Christmas Manger" (formerly named "Bethlehem Ranch") by Universal Pictures Home Entertainment, the home video distribution division of Universal Pictures. The launch of these two films marks the completion of the first two films of a multi-film financing agreement between Almost Never Films and Pure Flix Entertainment.

This past December, Almost Never Films announced that ION Television acquired the Company's holiday feature "Country Christmas Album". The network aired the film during 2018's holiday season. ION Television is a foremost family-oriented entertainment network. ION Television is a top 10-ranked U.S. general entertainment network. It is the flagship of the independent, privately held media company, ION Media. ION Media's 70 full-power stations reach 102 million homes.

The people behind Almost Never Films are originally from the finance industry. The Company is made up of private equity and investment professionals that have a passion for motion pictures.

Almost Never Films, Inc. (HLWD), closed Tuesday's trading session at $0.62, up 3.33%, on 440 volume with 3 trades. The average volume for the last 3 months is 12,045 and the stock's 52-week low/high is $0.30/$2.51.

chart

FISION Corp. (FSSN)

NetworkNewsWire, Penny Stock Tweets, Stockhouse, InvestorsHub, InvestorPoint, The Street, Wallet Investor, Market Screener, OTC Markets, Stockwatch, Dividend Investor, Investing, YCharts, Barchart, TradingView, MarketWatch, Business Wire, GuruFocus, and Capital Market Access reported earlier on FISION Corp. (FSSN), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

FISION Corp. is a cloud-based digital asset management and marketing automation company. It serves enterprise clients in the healthcare, hospitality, financial/insurance, software, and technology industries. The Company is an effective sales enablement and marketing asset management tool. Established in 2011 and OTCQB-listed, FISION is based in Minneapolis, Minnesota.

FISION maximizes the brand potential of every sales interaction. The Company's advanced, proprietary technology specializes in managing customers' brand and marketing content. This enables marketing and sales people to quickly and easily create compelling, personalized, on-brand communications that increase revenue and profits.

FISION equips marketing and sales teams with a wide-ranging set of enablement capabilities built to solve distributed marketing challenges. FISION's solutions include simplified brand distribution, sales enablement, distributed & localized marketing, digital asset management, channel support, and measurement & analytics. FISION's centralized, cloud-based library supports manifold different file types. It gives a client complete control over how company assets are stored, retrieved, and used.

FISION completed the acquisition of Volerro Corporation (Minneapolis, Minnesota-based) following the announcement of a definitive purchase agreement on April 25, 2017. Volerro is a leader in cloud-based content collaboration and agile marketing technology. Volerro enhances the FISION platform with complementary cloud-based collaboration, agile marketing, and sales enablement software. Volerro's ReVu.Me cloud app allows team members to work on the same document in real-time with integrated chat and voice conferencing.

In August 2018, FISION announced a merger agreement with Continuity Logic LLC. FISION's "front of the house" sales and marketing solution is complemented by Continuity Logic's "back of the house" enterprise integration & user-friendly application interface. This agreement in 2018 allowed both companies to immediately take advantage of each others customer base and sales pipeline, with no current overlapping of clients.

In October 2018, FISION announced it was named the #1 software company in Minnesota by Twin Cities Business (TBC) magazine. FISION is the category winner in the publication's 2018 Best of Business Reader's Choice Awards. FISION currently has greater than 65,000 users across 21 countries.

FISION Corp. (FSSN), closed Tuesday's trading session at $0.055, up 14.58%, on 297,190 volume with 21 trades. The average volume for the last 3 months is 190,864 and the stock's 52-week low/high is $0.027/$0.259.

chart

BioVie, Inc. (BIVI)

NetworkNewsWire, Penny Stock Tweets, Stockhouse, Investor Place, Wallmine, Wealth Insider Alert, InvestorsHub, Morningstar, YCharts, EuroInvestor, MarketWatch, GuruFocus, Street Insider, and Simply Wall St reported earlier on BioVie, Inc. (BIVI), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

BioVie, Inc. focuses on the discovery, development, and commercialization of unique drug therapies for liver disease. At present, the clinical-stage Company is centering on commercializing BIV201. This is a novel approach to the treatment of ascites due to chronic liver cirrhosis. OTCQB-listed, BioVie has its corporate headquarters in Beverly, Massachusetts.

The Company states that BIV201 has the potential to improve the health of thousands of patients suffering from life-threatening complications of liver cirrhosis due to hepatitis, NASH, and alcoholism. The US Patent and Trademark Office (USPTO) issued US Patent No. 9,655,945 covering BioVie's new drug candidate BIV201.

BIV201 has Orphan Drug designation for the most common of these complications, ascites, which represents a major unmet medical need. The Food and Drug Administration (FDA) has never approved any drug specifically for treating ascites.

BIV201 is a continuous infusion of the peptide terlipressin, first undergoing development for the treatment of refractory ascites. Terlipressin, dosed differently, is approved in about 40 nations for other complications of liver cirrhosis coming up from a similar disease pathway. Terlipressin is not available in the United States.

BioVie announced in April 2017 that it received notice from the FDA that the planned Phase 2a clinical trial of its new drug candidate BIV201 could begin. This was based on BioVie's IND to conduct a study in patients with refractory or intractable ascites due to advanced liver cirrhosis. BioVie also announced in April 2017 the signing of a Cooperative Research and Development Agreement (CRADA). This is to conduct a Phase 2a clinical trial of BIV201 in patients with refractory or intractable ascites because of advanced liver cirrhosis.

The FDA has granted Fast Track designation for BIV201 (continuous infusion terlipressin), BioVie's patented Orphan drug candidate. BIV201 is currently undergoing evaluation for the treatment of refractory ascites because of liver cirrhosis in a mid-stage (Phase 2a) U.S. clinical trial.

The FDA has granted Orphan Drug designation to BioVie for terlipressin for the treatment of hepatorenal syndrome (HRS). BioVie earlier secured an Orphan Drug designation for terlipressin for treating ascites. The Company is exploring additional Orphan designation opportunities.

This month, BioVie announced that it completed enrollment in a Phase 2a open-label clinical study of BIV201 (continuous infusion terlipressin) in patients with refractory ascites because of advanced liver cirrhosis.

Patrick Yeramian, MD, BioVie's Chief Medical Officer, said, "We are pleased to have achieved this important clinical milestone as we continue to develop BIV201 for patients with refractory ascites who are at high risk of deadly complications. What we have learned from this initial study is informing our next clinical trial design. The results will be presented to the FDA in the first half of 2019 and we expect to receive guidance on the BIV201 clinical development plan."

BioVie, Inc. (BIVI), closed Tuesday's trading session at $0.085, up 7.73%, on 190,000 volume with 20 trades. The average volume for the last 3 months is 120,385 and the stock's 52-week low/high is $0.012/$0.25.

chart

The Pocket Shot Company (PCKK)

Wallet Investor, Wallstreet Online, Stockopedia, InvestorsHub, GuruFocus, Street Insider, Wallmine, Market Exclusive, Dividend Investor, Seeking Alpha, MarketWatch, Stockhouse, and Financial Content reported on The Pocket Shot Company (PCKK), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

The Pocket Shot Company is a specialty alcohol beverage distribution company listed on the OTC Markets. Fundamentally a portable spirit enterprise, it designs, produces, and distributes hard liquor and other beverages in flexible single-serving pouches in the U.S. The Company offers Pocket Shot, which is a grab and go package for alcoholic beverages. Pocket Shot Company is based in Denver, Colorado.

The Company's goal was to create a user friendly, safe, mass production style pouch that could hold a broad array of flavors. The Company offers Pocket Shot in bourbon, whiskey, rum, vodka, brandy, tequila, cherry vodka, cinnamon whiskey, peppermint schnapps, spiced rum, and cinnamon schnapps flavors.

Pocket Shot can be found in more than 25 states. It sells in thousands of stores. Pocket Shot Company also offers its products via online retailers.

Last month, The Pocket Shot Company announced it completed its anticipated merger with Pure Harvest Cannabis Producers. Pure Harvest is a privately held Nevada company led by a group of cannabis industry pioneers. This merger will immediately permit Pocket Shot to enter the fast expanding cannabis, hemp, and CBD industry.

The post-merger company will immediately concentrate on developing into a multi-state, seed-to-sale, vertically integrated cannabis and hemp producer and retailer under the Pure Harvest brand. The enhanced brand will now include a unique beverage line of premium CBD infused products for energy and sports recovery.

Yesterday, The Pocket Shot Company announced that its Pure Harvest Cannabis Producers, Inc. subsidiary executed a Letter of Intent (LOI) for a large scale cannabis/CBD processing and production joint venture (JV) in Colombia on a prime 200 hectare (494 acre) site. This gives Pocket Shot Company a premier footprint for processing and production for export of cannabis derivatives into major legal markets internationally. This project will be directed by a newly created wholly-owned subsidiary, Pure Harvest Colombia Partners Ltd, which is a Canadian corporation.

The Pocket Shot Company (PCKK), closed Tuesday's trading session at $1.10, up 11.11%, on 2,000 volume with 7 trades. The average volume for the last 3 months is 1,727 and the stock's 52-week low/high is $0.109/$2.20.

chart

Cocrystal Pharma, Inc. (COCP)

Microcapmillionaires, Stock Twits, Tip Ranks, YCharts, Street Insider, Proactive Investors, MarketWatch, Stockwatch, Simply Wall St, Business Wire, Seeking Alpha, Promotion Stock Secrets, Wall Street Resources, The Street, Stockhouse, Penny Stocks Forever, GuruFocus, Equity Clock, Market Screener, Barchart, and Investors Hub reported previously on Cocrystal Pharma, Inc. (COCP), and today we are reporting on the Company, here at the QualityStocks Daily Newsletter.

Cocrystal Pharma, Inc. develops novel antiviral therapeutics as treatments for serious and/or chronic viral diseases. The Company uses unique technologies and Nobel Prize winning expertise to create first- and best-in-class antiviral drugs. The design of these technologies, including its nucleoside chemistry expertise and market-centered approach to drug discovery, are to efficiently deliver small molecule therapeutics, which are safe, effective, and convenient to administer. A biotechnology enterprise, Cocrystal Pharma is headquartered in Bothell, Washington.

The Company's proprietary technologies revolve around a structure-based drug discovery strategy teamed up with extensive nucleoside experience. Utilizing techniques called protein cocrystallization and X-ray crystallography, Cocrystal Pharma quickly identifies novel binding sites, identifies critical inhibitor-protein interactions, and optimizes the structure of the inhibitor in a highly rapid iterative fashion. The Company has identified promising, preclinical stage antiviral compounds for unmet medical needs. These include hepatitis, influenza, and norovirus infections.

Cocrystal is developing a series of compounds that are potent non-nucleoside and nucleoside inhibitors of hepatitis C NS5B RNA dependent RNA polymerase, a replication enzyme vital to viral replication and are highly conserved between all hepatitis C genotypes. Therefore, inhibitors of this enzyme are likely to have multi- or pan-genotypic activity.

In addition, the Company is developing compounds that inhibit hepatitis C helicase and NS5A, two enzymes important for viral replication. Cocrystal has also identified a picomolar inhibitor of NS5A; another crucial viral replication protein.

Last month, Cocrystal Pharma announced that it entered into an exclusive license and collaboration agreement with Merck to discover and develop certain proprietary influenza A/B antiviral agents. With this agreement, Merck will fund research and development (R&D) for the program, including clinical development. Merck will be responsible for global commercialization of any products derived from the collaboration. Cocrystal Pharma will be paid an undisclosed upfront sum. Cocrystal is eligible to receive payments related to designated development, regulatory and sales milestones with the potential to earn up to $156 million and undisclosed royalties on product sales.

Additionally, last month, Cocrystal Pharma announced safety and preliminary efficacy data for its U.S. Phase 2a study evaluating CC-31244 for the ultra-short treatment of HCV infected individuals. CC-31244 is an investigational, oral, potent, broad-spectrum replication inhibitor called a non-nucleoside inhibitor (NNI).

The treatment was well tolerated with no study discontinuations because of adverse events. Eight of 12 subjects achieved the primary efficacy endpoint of sustained virologic response at 12 weeks after completion of treatment (SVR12). SVR12 is defined as undetectable virus in blood 12 weeks after completion of treatment and considered a virologic cure.

Cocrystal Pharma, Inc. (COCP), closed Tuesday's trading session at $2.70, up 1.89%, on 5,604 volume with 25 trades. The average volume for the last 3 months is 13,062 and the stock's 52-week low/high is $1.51/$5.50.

chart

The QualityStocks Company Corner

TransCanna Holdings Inc. (CSE: TCAN)

The QualityStocks Daily Newsletter would like to spotlight TransCanna Holdings Inc. (CSE: TCAN).

TransCanna Holdings Inc. (CSE: TCAN) (FSE: TH8) announced that it completed the purchase of a 196,000 square foot vertically integrated cannabis facility. Also today, the company was featured in a publication from GlobeNewswire, examining how TCAN has positioned itself to capitalize on the evolving dynamics in cannabis branding.

TransCanna Holdings Inc. (CSE: TCAN) through its subsidiaries specializes in assisting clients who are cannabis farmers and manufacturers get recognized by end consumers who in turn purchase their products. TransCanna offers or will be offering services to support almost every aspect of the cannabis-related eco-system; from branding and design, to transportation and distribution, to marketing and sales.

California’s legalized adult-use recreational marijuana market opened for business January 1, 2018. The state’s Bureau of Cannabis Control is responsible for regulating all commercial activities in the state including cultivation, distribution and transportation. Moving cannabis products in the California marketplace is extremely challenging due to municipal and state laws and regulations, which can differ among cities and counties. Since cannabis remains illegal under federal law, Department of Transportation regulated companies are barred from participating in the market, which means companies looking to excel in the sector must hold a state-issued distributor license from the Bureau of Cannabis Control.

TransCanna has already entered into an Intellectual Property Rights and Royalty Agreement for the Track & Trace software platform required by the state of California. TCM Distribution, the operating company managed by TransCanna, has received a transportation and distribution permit from the city of Adelanto and a temporary transportation and distribution permit from the state of California. TransCanna has also executed a land lease to build a 10,000-square-foot transportation and distribution facility in Adelanto.

TransCanna is strategically creating a distribution network throughout California that places its facilities no further than a three-hour drive from most any client. The company is in the process of leasing or purchasing properly licensed and permitted warehouses strategically located throughout California along with new secure trucks, sprinter vans and/or armored vehicles.

TransCanna plans to create its own portfolio of branded products for the cannabis and hemp sectors. The company’s management team intends to translate the skills, knowledge and experience gained from a combined 60 years of branding and marketing experience in the music, professional sports and alcohol industries into TransCanna and the cannabis industry.

As part of the “TransCanna Way,” the company intends to manage most aspects of the supply chain from upper end procurement, branding, transportation and distribution, to marketing and sales.

Leading TransCanna as its CEO and chairman is James Pakulis, who has three decades of experience working with public and private entrepreneurial companies in a variety of emerging and high-growth sectors. He is formerly the president and a director of Lifestyle Delivery Systems Inc. (CSE: LDS) (OTCQB: LDSYF), a vertically integrated cannabis-related entity operating in California. Pakulis was chairman and CEO of General Cannabis Inc. which from 2010 to 2012 owned WeedMaps. Pakulis oversaw the company’s growth from zero to over $16 million in annual revenue in less than 24 months.

The company’s strategic advisors include individuals with extensive experience in branding, marketing, sales, distribution, production and supply chain management.

For additional information, call: (604) 609-6199

TransCanna Holdings Inc. (CSE: TCAN), closed the day's trading session at $6.02, up 2.73%, on 263,967 volume with 212 trades. The average volume for the last 3 months is 137,074 and the stock's 52-week low/high is $0.769/$6.04.

Recent News

chart

Youngevity International, Inc. (NASDAQ: YGYI)

The QualityStocks Daily Newsletter would like to spotlight Youngevity International, Inc. (YGYI).

Youngevity International, Inc. (NASDAQ: YGYI), a leading multi-channel lifestyle company, today reported financial results for the fourth quarter and full year ended December 31, 2018.

Youngevity International, Inc. (NASDAQ: YGYI) is a leading omni-direct lifestyle company offering a hybrid of the direct selling business model that includes e-commerce and the power of social selling. Among the Top 100 Global Direct Selling Companies, Youngevity offers products from the six top selling retail categories: health/nutrition, home/family, food/beverage (including coffee), spa/beauty, apparel/jewelry, and a range of innovative services. Created through the 2011 merger of Youngevity Essential Life Sciences with Javalution® Coffee Company, today’s Youngevity International Inc. is a virtual worldwide Main Street of products and services under one corporate entity that supports a healthy and empowered lifestyle.

Youngevity International is dedicated to improving lifestyles through the universal desires of vibrant health and flourishing economics. Catering to health-conscious consumers, Youngevity believes that combining the best of the direct selling industry with the fundamentals and capabilities of a traditional business model will maximize shareholder value. The company’s Nutritional, Lifestyle and Telecommunications products and services are distributed through a global network of Preferred Customers and Distributors.

Youngevity’s wholly owned CLR Roasters LLC business line offers quality branded and private label coffee to retail stores, office coffee services, hospitality, food services, distributors, convenience, petrol stores and vending businesses. Today, CLR Roasters is the largest coffee provider for cruise lines in North America and the second largest roaster in the state of Florida. Producing a consistent premium product with superior taste, CLR Roasters has earned numerous certifications that demonstrate the company’s commitment to the craft of providing the highest quality coffee products using the best practice standards available.

Youngevity, operating in the direct-selling channel, is rapidly expanding its product and distributor base through acquisitions and mergers under an innovative concept called “the Network Cloud” that provides other direct selling companies with a home base. The company’s YoungevityGO2 mobile distributor app, a new technology-driven web platform supporting expansion of global e-commerce and social selling platforms, is available on Google Play and the App Store. In addition to the Network Cloud concept, Youngevity International owns CLR Coffee Roasters which operates a traditional coffee roasting business offering a JavaFit® gourmet product line that vertically integrates with Youngevity and its growing network of direct marketers.

Youngevity International offers more than 1,000 high quality, technologically advanced products under the following categories:

  • Health and Nutrition
  • Home and Family
  • Food and Beverage
  • Spa and Beauty
  • Fashion
  • Essential Oils
  • Photo and scrapbooking
  • Services for Home and Business

Youngevity International Inc. has compiled a best-in-class management team with a strong track record of success in private and public companies. Steve Wallach, CEO, has nearly two decades of sales and network marketing experience and has successfully guided Youngevity International Inc. to become an international, publicly-traded direct marketing company positioned for worldwide growth. Dave Briskie, president and CFO, has shepherded the company’s development into a fully vertical coffee roasting and distribution company that owns the direct marketing brand JavaFit® and the retail brand, Café La Rica.

Youngevity has also attracted a stunning group of Brand Evangelists who endorse its products. Among these are actress, author and well-known health and wellness activist Marilu Henner; former NBA basket player, Mike “Stinger” Glenn; former NFL wide receiver Drew Pearson; “Greatest Natural Bodybuilder in the World” Gene Nelson; and WNBA champion, Olympic gold medalist Delisha Jones.

Youngevity International, Inc. (NASDAQ: YGYI), closed the day's trading session at $5.73, up 6.70%, on 83,476 volume with 509 trades. The average volume for the last 3 months is 191,083 and the stock's 52-week low/high is $3.167/$16.25.

Recent News

chart

Plus Products Inc. (CSE: PLUS) (OTC: PLPRF)

The QualityStocks Daily Newsletter would like to spotlight Plus Products Inc. (CSE: PLUS) (OTC: PLPRF).

PLUS Products Inc. (CSE:PLUS) (OTCQB:PLPRF), a cannabis branded product manufacturer dedicated to making cannabis safe and approachable, is pleased to announce that co-founder and Chief Executive Officer Jake Heimark, will present at the 3rd Annual Benzinga Cannabis Capital Conference, held on April 17-18 at the Fairmont Royal York in Toronto, Canada. Jake will be speaking on the 18th at 1:20PM EST.

Plus Products Inc. (CSE: PLUS) (OTC: PLPRF) is a branded cannabis-infused products manufacturer of edibles created to support a healthy and active lifestyle. Headquartered in San Mateo, California, PLUS™ concentrates on producing edibles using extracts to ensure compliant, dosable and delicious products that provide a consistent cannabis experience.

First introduced to the market in 2015 to rave reviews, PLUS™ is now one of the top best-selling edible brands in California. PLUS™ operates through a wholly owned subsidiary, Carberry, and has four cannabis-infused gummy candy SKUs (in addition to limited edition SKUs), that are currently sold in over 200 licensed dispensaries and delivery services. All products under the PLUS™ brand are produced in the company’s 12,000-square-foot food-safe cannabis manufacturing facility in Adelanto, California.

PLUS Products shares are currently listed on the Canadian Securities Exchange. PLUS™ raised CAD$20 million through the offering, for which the lead underwriters were PI Financial and Canaccord Genuity. The company intends to use a portion of the IPO proceeds to fund rapid product capacity expansion, factory automation, working capital and new product development.

Operating in the largest adult-use recreational market in the U.S., PLUS Products holds a temporary manufacturing license in California and was one of the first brands to bring fully compliant products to the legal market. California legalized adult use recreational sales on Jan. 1, 2018, and industry analysts expect edible sales there will continue to amass enviable revenues. According to BDS Analytics, edibles made up 18 percent of marijuana retail sales in February 2018 across licensed retailers in California, with PLUS™ products ranking in the Top 10 of edible brands by retail dollar sales.

During the first half of 2018, PLUS Products generated US$2.45 million in sales, a marked improvement over 2017’s US$1.07 million in sales. The company’s established cannabis products are not only compliant with state laws, they are proving to be extremely popular with consumers. Among the PLUS™ product brands are:

  • Blackberry & Lemon RESTORE, an infusion of carefully dosed cannabis with a 9:1 THC to CBD per gummy.
  • Sour Watermelon UPLIFT, a low-calorie gummy crafted from carefully dosed cannabis with an infusion of 5mg THC per gummy.
  • Pineapple & Coconut CBD RELIEF, a tropical flavor gummy made from pure cannabis-derived CBD that is low-calorie, gluten-free and made with kosher ingredients.
  • Sour Blueberry CREATE, a low-calorie gummy infused with hybrid flower containing 5 mg THC.
  • Limited Edition Rose & Vanilla, available at select locations during Winter 2018, these gummies are crafted with 60 mg THC/30 mg CBD per tin.
  • Limited Edition RAINBOW SORBET gummies was created to celebrate Pride during Spring 2018 with a portion of each purchase donated to The Trevor Project, a confidential suicide hotline for LGBT youth.

“We are extremely proud of the products PLUS has brought to market,” remarked Jake Heimark, CEO and cofounder in a statement. “We’ve quickly grown into one of the leading edible brands in California. With the proceeds of this round, we will continue to further our mission: to make cannabis safe and approachable for all types of consumers.”

The PLUS™ team believes that everyone deserves access to consistent, dosable and delicious cannabis products and strives to make that happen. Producing the best infused products at scale requires thoughtful collaboration among experts in many fields. At PLUS™, our team is comprised of Chefs, Chemists, Food Manufacturing Experts, Engineers, Machinists, Visionaries, Creatives, Strategists and others.

Plus Products Inc. (PLPRF), closed the day's trading session at $4.2299, up 8.74%, on 70,469 volume with 150 trades. The average volume for the last 3 months is 82,568 and the stock's 52-week low/high is $2.81/$6.01.

Recent News

chart

Canopy Rivers Inc. (TSX.V: RIV) (OTC: CNPOF)

The QualityStocks Daily Newsletter would like to spotlight Canopy Rivers Inc. (RIV) (CNPOF).

Canopy Rivers Inc. (TSX.V: RIV) (OTC: CNPOF) and High Beauty, Inc. ("High Beauty") are pleased to announce the completion of an investment by Canopy Rivers in High Beauty, creator of industry-leading cannabis beauty brand high. Canopy Rivers has subscribed for US$2.5 million of shares in High Beauty, representing 18.4% of the company on a fully diluted basis, including additional warrant coverage. Also today, the company was featured in the 420 with CNW by CannabisNewsWire.

Canopy Rivers Inc. (TSX.V: RIV) (OTC: CNPOF) is the venture capital investment platform of Canopy Growth Corporation (TSX:WEED, NYSE:CGC).

Canopy Rivers is a unique investment and operating platform structured to pursue investment opportunities in the emerging global cannabis sector. Canopy Rivers collaborates with Canopy Growth to identify strategic counterparties seeking financial and/or operating support. Headquartered in Toronto, Canada, Canopy Rivers has developed an ecosystem of complementary cannabis operating companies operating throughout the cannabis value chain.

Canopy Rivers, in collaboration with Canopy Growth, has established a diverse portfolio of cannabis industry investments that includes domestic and international companies, licensed producers, late-stage licensed producer applicants, pharmaceutical formulators, brand developers and distributors, retail networks, and technology and media platforms. Investments are customized for each counterparty and include a balanced mix of equity, debt, royalty and profit-sharing agreements.

Canopy Rivers’ expanding portfolio includes:

  • Agripharm Corp. (private) is an ACMPR licensed producer, acquired by Canopy Growth in January 2017. In November 2017 Agripharm completed a joint venture with globally recognized partners Green House Seeds and Organa Brands. Canopy Growth has sublicensed proprietary technology, trademarks, genetics, know-how and other intellectual property from Agripharm to distribute the suite of Green House and Organa Brands products across the country, when permissible.
  • CanapaR Corp. (private) owns 80% of CanapaR Italy, a Sicily-based company focused on developing and commercializing Italy’s local hemp cultivation industry through its partnership with the renowned Department of Agriculture at the University of Catania and its rapidly building extraction capabilities for the production of organic CBD oil. CanapaR Italy’s outsource farming model with local Sicilian farmers and its university partnership will provide it with a low-cost source of organic CBD oil, which is increasingly used as an input into new commercial products in the growing health and wellness industries.
  • Civilized Worldwide Inc. (private), is a media and lifestyle brand with offices in New Brunswick and California that embraces and highlights modern cannabis culture. Civilized aims to engage the millions of productive, motivated people who choose to enjoy cannabis responsibly as part of their lifestyle. Reaching 2+ million unique visitors per month, North America-wide, Civilized produces engaging content for and about people who enjoy cannabis responsibly.
  • James E. Wagner Cultivation Ltd. (TSXV:JWCA) was founded in 2007 by third generation agricultural and cannabis cultivators. JWC is the first entirely aeroponic producer of cannabis in Canada, and its patent-pending aeroponic production technology, called GrowthStormTM, allows for perpetual harvesting and improved yields. The company was issued a license to cultivate from Health Canada in January 2017 and a subsequent sales license in March 2018.
  • LiveWell Foods Canada Inc. (TSXV:LVWL) was established in 1993 as a nutritional lifestyle company, and operates in the production of fresh produce and food technology. The company’s O-Hemp division distributes bulk and retail hemp products through its existing channel partners. LiveWell entered into a strategic agreement with Canopy Rivers and Canopy Growth in April 2018.
  • PharmHouse (private) is a joint venture between Canopy Rivers and the principals and operators of leading North American greenhouse produce companies. PharmHouse has arranged to acquire a newly built 1.3-million-square-foot greenhouse located in Leamington, Ontario.
  • Radicle Cannabis Inc. (private) is an ACMPR-licensed cannabis company based in Hamilton, Ontario backed by a management team that brings extensive experience in regulated industries, retail distribution, tobacco and pharmaceutical development, as well as Award-winning cannabis horticulturist breeders and medical professionals.
  • Solo Growth (TSXV:ALZ) is a new cannabis retail concept that will operate locations under the name “YSS by Solo,” relying on the expertise of a management team comprised of founding shareholders, senior officers and board members of Solo Liquor Stores Ltd., a leading Canadian liquor retailer. Solo Growth was established through a recapitalization of Aldershot Resources Ltd.’s corporate structure that will allow the company to execute a new retail-focused cannabis business strategy.
  • Spot Therapeutics Inc. (private) is an applicant that was acquired by Canopy Growth in August 2017 to solidify its Maritimes expansion strategy and less than four weeks later Canopy Growth signed a supply MOU with the New Brunswick government. Canopy Rivers purchased the property and entered into a long-term lease and committed funding agreement with Canopy Growth.
  • TerrAscend Corp. (CSE:TER) cultivates high-quality cannabis in an indoor hydroponic facility, backed by a strategic investor boasting a strong background in the pharmaceutical space and an extensive portfolio of specialty pharma assets.
  • Vert Mirabel (private) is a joint venture that was established in December 2017 between Canopy Rivers, Canopy Growth, and Les Serres Stephane Bertrand. Bertrand is a large-scale greenhouse operator located in Mirabel, Quebec, and the largest grower of pink tomatoes in the country. With guidance and assistance from Canopy Growth, the greenhouse has been upgraded and retrofitted for cannabis production and was licensed by Health Canada in May 2018.

As the company’s portfolio continues to develop, each constituent benefits from opportunities to collaborate with Canopy Growth and among themselves. Canopy Rivers believes this formula results in an ideal environment for innovation, synergy and value creation for Canopy Rivers, Canopy Growth and across the entire Rivers ecosystem.

Canopy Rivers is led by an experienced team of qualified financial and technical professionals with deep industry experience and relationship networks. The company’s acting CEO and chairman is Bruce Linton, CEO of Canopy Growth and founder of Tweed Marijuana.

Canopy Rivers Inc. (TSX.V: RIV), closed the day's trading session at $3.68, up 4.84%, on 826,703 volume with 1,190 trades. The average volume for the last 3 months is 622,509 and the stock's 52-week low/high is $2.40/$11.82.

Recent News

chart

Lexaria Bioscience Corp. (CSE: LXX) (OTC: LXRP)

The QualityStocks Daily Newsletter would like to spotlight Lexaria Bioscience Corp. (LXRP).

Lexaria Bioscience Corp. (OTCQX: LXRP) (CSE: LXX) (the "Company" or "Lexaria"), a drug delivery platform innovator, advises that in connection with yesterday's announcement regarding the engagement by Lexaria of Oak Hill Financial Inc. ("Oak Hill"), the agreement with Oak Hill has a one month term that is automatically renewed, subject to termination by either party, upon five business days notice. The monthly compensation payable to Oak Hill is $8,500.

Lexaria Bioscience Corp. (CSE: LXX) (OTC: LXRP) has developed and out-licenses its proprietary technology for improved taste, rapidity, and delivery of bioactive compounds, including nicotine and cannabinoids. To achieve higher absorption rates and fast onset, consumers traditionally defaulted to smoking. Lexaria provides a superior administration method by delivering these substances through a patented process within edible food products, thus eliminating all the harmful health consequences of smoking.

Lexaria’s technology is unique in that it takes advantage of GRAS (Generally Recognized As Safe) food ingredients processed with its patented DehydraTECHTM technology to improve taste, remove odor, and decrease the time to onset of bitter-tasting drugs. Lexaria is primarily a B2B enterprise and has existing cannabinoid licensing agreements with companies in Canada, the largest-market states in the United States, and internationally. Lexaria has entered into a R&D partnership with one of the largest cigarette companies in the world for oral forms of nicotine delivery. Lexaria has also developed its own brands partly for demonstration purposes, utilizing its patented technology to infuse hemp oil ingredients within popular foods such as coffee, tea, and supplements. These brands include ViPova™ and TurboCBD™.

In 2015, Lexaria commissioned an independent third-party lab to test its technology under carefully monitored in vitro conditions. Results showed that the company’s technological process and lipid formulation improve intestinal absorption as much as 500%. Lexaria has conducted multiple rounds of studies including in vivo and human clinical. In absorption studies conducted on rats, for example, Lexaria detected nicotine in the animal’s bloodstream just two minutes after it entered the stomach. In a randomized, double blinded human clinical study, cannabidiol (CBD) was measure in the human bloodstream at a 317% higher rate 30 minutes after swallowing a capsule processed with DehydraTECH than a non-enhanced capsule of equal strength.

Lexaria also has an R&D partnership with the Canadian government’s National Research Council. That R&D is expected to characterize molecular bond formation theorized to occur with Lexaria’s unique technology between the lipid delivery agents and the bioactive substances it processes and combines. Results from this R&D have helped support B2B relationships with Fortune 500 companies. Lexaria has four distinct subsidiaries that focus on different market sectors: Hemp/CBD; Pharmaceutical; Cannabis; and Nicotine.

Aside from testing, a critical component of Lexaria Bioscience’s business model is a strong and growing intellectual property portfolio. As of the end of 2018, the company’s patent portfolio includes 53 patent applications filed and pending in more than 40 countries around the world; and 10 patents granted to date. Lexaria is expecting additional new patent awards both in the U.S. and internationally in 2019 and beyond. Some of its more recent areas of investigation have included human hormones and erectile dysfunction substances, among others.

Royalties play a vital role in Lexaria’s revenue-generating business model. The company out-licenses its technology (royalty) to third-partners and has signed royalty deals with start-up companies as well as with a Fortune 100. The company’s growth initiatives are guided by a management team headed by CEO Chris Bunka, a serial entrepreneur who has contributed to several multi-hundred million-dollar valuations over the course of his career. He is supported by a growing team of professionals with extensive experience in pharmaceutical and bioscience sectors, invention, toxicology, consumer goods, and other relevant skillsets.

Lexaria Bioscience Corp. (LXRP), closed the day's trading session at $1.19, up 5.31%, on 98,723 volume with 116 trades. The average volume for the last 3 months is 153,174 and the stock's 52-week low/high is $0.75/$2.43.

Recent News

chart

Green Hygienics Holdings Inc. (GRYN)

The QualityStocks Daily Newsletter would like to spotlight Green Hygienics Holdings Inc. (GRYN).

Green Hygienics Holdings Inc. (OTCQB: GRYN) ("GRYN" or the "Company"), an innovative, full-scope, science-driven, premium cannabis cultivation and branding enterprise, is pleased to announce it has entered into a Letter of Intent for the acquisition of Coastal Labs.

Green Hygienics Holdings Inc. (GRYN) is a full-scope, premium cannabis cultivation company targeting the high-end medical and adult-use recreational market. With more than 25 years of experience in agricultural science and innovation, Green Hygienics is establishing itself as a leader in the advancement of science-driven cannabis cultivation systems. The company will grow by generating revenues from the sales of premium grade cannabis products, developing and licensing valuable IP, making strategic acquisitions, and creating trusted global consumer brands.

The company has integrated and is developing its own IP assets related to proprietary systems and apparatus, software, algorithms and custom-engineered hardware. This provides ultimate efficiencies in a commercially controlled cultivation environment. Utilizing the advantages of hybrid-aeroponics, Green Hygienics creates a sterile growing environment that produces consistent, high-quality product while maintaining the lowest possible carbon footprint. The company utilizes state-of-the-art, quality-controlled commercial cultivation methodology to assure production of pharmaceutical-grade cannabis at much higher yields and greatly reduced costs.

Hybrid-aeroponics produces quality cannabis faster than traditional methods since it doesn’t require natural sunlight or soil and can be operational and produce plants anywhere. Plants grown under aeroponic conditions receive water and nutrients directly to their roots via a fine mist in a controlled environment, dramatically reducing spoilage while keeping the product organic and the environment pest-free. The plants are given the exact amount of nutrients and moisture precisely when needed. Green Hygienics maintains ultimate control over every aspect of this cultivation process, which allows the company to operate with conservation of natural resources in mind. The technology that uses 90-95 percent less water and does not require the use of pesticides or fungicides.

Additionally, the company’s state-of-the-art engineered, controlled environments include electrical, mechanical and HVAC designs that meet mandatory fire and energy codes while improving energy efficiency significantly.

Through these practices, Green Hygienics is establishing itself as a leader in the advancement of science-driven cannabis cultivation systems. The company continues to develop and incubate software as well as engineer hardware to provide additional control over the commercial cultivation method. The company’s science-based approach reveals any growth anomalies before the human eye can see them. This makes it possible to monitor all facets of production, identify cultivation problems based upon scientific data, and implement immediate corrective action, if needed.

The future of commercial cannabis cultivation hinges on using science to control the growing environment in order to remain competitive and deliver a premium grade of product on a consistent basis. The company holds a competitive advantage through its ability to produce premium cannabis products at a significantly lower cost per gram than direct competitors and others in the cannabis industry.

Innovations within the sector that create efficiencies and successful brands will become highly valued. Green Hygienics and its forward-thinking management team are constantly studying the market dynamics of the cannabis industry in North America and abroad while actively pursuing possible expansion opportunities. The company is headquartered in Las Vegas, Nevada and establishing operations in San Diego, California, targeting the $5 billion California cannabis market.

Green Hygienics Holdings Inc. (GRYN), closed the day's trading session at $0.6675, up 5.95%, on 31,239 volume with 18 trades. The average volume for the last 3 months is 27,304 and the stock's 52-week low/high is $0.07/$0.722.

Recent News

chart

Nightfood Holdings, Inc. (OTCQB: NGTF)

The QualityStocks Daily Newsletter would like to spotlight Nightfood Holdings, Inc. (NGTF).

Nightfood, Inc. (OTCQB: NGTF), the innovative company solving America's $50 billion-dollar nighttime snacking problem, announced today that Lowes Foods, a supermarket chain with significant presence in the Carolinas, has begun stocking Nightfood ice cream into all 78 Lowes locations.Also today, the company was highlighted in the Venture Breakfast Bits, by 24/7 Market News.

Nightfood Holdings, Inc. (OTCQB: NGTF), a pioneering consumer goods brand development company headquartered in Tarrytown, New York, owns Nightfood, Inc., creator of delicious, award-winning and better-for-you ice cream formulated by sleep and nutrition experts, and its wholly owned subsidiary MJ Munchies, Inc., which seeks to capitalize on legally compliant opportunities in the CBD and marijuana edibles and related spaces. Known as “The Nighttime Snack Company,” Nightfood Inc. is focused on improving the late-night snacking choices of consumers while solving America’s $50 billion-dollar nighttime snacking problem.

Nightfood Ice Cream

Nightfood’s higher-protein and sleep-friendly ice cream won the 2019 Product of the Year Award in a survey of over 40,000 consumers. The annual Product of the Year survey, the world’s largest consumer-voted award for product innovation, is conducted by Kantar, a global leader in consumer research. In beating out the other finalists, consumers indicated that Nightfood’s one-of-a-kind innovation and unique value proposition made it a clear-cut winner in the ice cream space and a brand they were highly motivated to try. Winners of the 32-year-old award have been shown to outperform category sales performance by over 38 percent.

Less than two months since manufacturing their first pint of ice cream, Nightfood has now secured distribution in more than 13 states, and has received extensive media coverage from outlets such as USA Today, Fox Business’ Mornings With Maria, Parents Magazine, The Food Network, MarketWatch, The Washington Post, Business Insider, Bustle, and more.

With the Product of the Year award and millions in media coverage, Management has publicly stated their goal of securing nationwide distribution in over 10,000 retail outlets by March 31, 2020.

Formulated by leading sleep and nutrition experts, including America’s most prominent sleep expert, Dr. Michael Breus, Nightfood’s higher protein/higher fiber, and lower sugar ice cream delivers great ice cream taste and texture, while minimizing sleep-disruptive ingredients such as caffeine, excess sugar, and excess fat and calories. The addition of certain minerals, enzymes and amino acids, which research suggests can support sleep quality, is another bonus. Nightfood only uses hormone-free milk, is certified Kosher, and offers eight original flavors, five of which are gluten-free. Nightfood ice cream also uses all-natural sweeteners with no Erythritol, no sucralose, or other artificial sweeteners.

More than 37,000 consumers across the country have already requested coupons for the company’s newly launched Nightfood ice cream by entering a giveaway hosted at NightfoodIceCream.com which includes a chance to win a one-year supply (96 pints) plus a freezer for storage. The coupon program is being run in conjunction with PromotionPod, which has previously conducted successful campaigns for brands such as Chobani, Halo Top, and BodyArmor.

Nightfood Inc. began its nationwide rollout of Nightfood ice cream in February 2019, successfully securing placement in Meijer supermarket locations in the Midwest with a concentration around the metropolitan areas of Chicago, Detroit, Indianapolis, Columbus and Milwaukee. A distribution agreement with New England Ice Cream Corporation (NEIC) will also place Nightfood ice cream in outlets located throughout Massachusetts, Vermont, New Hampshire, Maine, Rhode Island and Connecticut.

Ice cream lovers in northern California will find Nightfood Ice Cream at various upscale, independent retail outlets in and around the San Francisco bay area serviced through a distribution agreement with Wonder Ice Cream Company, which services thousands of retail outlets from Bakersfield north to the Oregon border. Consumers can also purchase Nightfood ice cream online at BuyNightfood.com through the Company’s partnership with IceCreamSource.com.

Ice cream is now the 2nd most popular night snack choice, with almost half of all consumers reaching for ice cream after dark. According to IRI Worldwide, 44 percent of all snack consumption occurs between dinner and bedtime, representing a consumer spend of over $1 billion weekly on nighttime snacks in the U.S. alone. Market research giant Mintel recently released a report identifying nighttime specific food and beverages as one of their most “compelling and category changing” trends for 2017 and beyond.

Nightfood has developed a dynamic infographic resource that clearly illustrates the size and scope of the largely untapped nighttime snack category (http://NightSnacking.com). Americans everywhere are likely to identify with the infographic’s results that vividly illustrate late night snacking by age group, popular snack choice, and amount of money spent each week on feeding after-hour snack attacks. Available in eight delicious flavors, Nightfood ice cream can help consumers satisfy nighttime cravings in a better, healthier, more sleep-friendly way.

MJ Munchies, Inc.

MJ Munchies, Inc., was formed in 2018 as a new, wholly owned subsidiary of Nightfood Holdings, Inc. to capitalize on legally compliant opportunities in the CBD and marijuana edibles and related spaces. The Company intends to market some of these new products under the trademarked brand name “Half-Baked” and has entered into a Letter of Intent that allows Global Consortium Inc. (OTC: GCGX) subsidiary Infused Edibles to receive an exclusive license to manufacture and distribute marijuana and CBD-infused products under the Half-Baked brand.

Management believes the Half-Baked brand will give the Company a unique and defensible competitive advantage against other recreational edible brands. The Company believes tremendous opportunities currently exist to launch successful and legally compliant products in this space, and that such opportunities will continue to grow over time.

Management Team

Nightfood founder and CEO Sean Folkson is a formerly frustrated nighttime snacker whose late-night cravings led him to seek a better solution for himself and others through the creation, marketing and distribution of the Nightfood product line. Folkson also founded internet marketing company AffiliatePros.com which provided the startup capital to launch Specialty Equipment Direct, an online distributor of floor removal equipment that quickly grew to 7-figure revenues. Folkson received a bachelor’s degree in business administration with a concentration in marketing from S.U.N.Y Albany, New York, in 1991.

Jim Christensen, vice president of Nightfood Ice Cream, is the former Vice President of Ice Cream Sales with global ice cream giant Unilever. In his over 20 years at Unilever, Jim led sales and distribution initiatives for brands such as Ben & Jerry’s, Klondike, Breyers and Good Humor. Christensen joined the Nightfood team in June of 2018 with the directive to launch Nightfood ice cream rapidly into national distribution through supermarket, drug, convenience and other channels. Understanding that the overwhelming majority of at-home ice cream consumption occurs in the hours before bed, Christensen has identified Nightfood as the next evolution in better-for-you ice cream.

CFO Mark Noffke, CPA, has over 37 years of experience as a seasoned financial and management professional. He has served as chief financial officer of several small cap public companies since 2004 where he oversaw virtually every aspect of the company’s operations, administration, customer service and human resources. Noffke has a bachelor’s degree in accounting from Valparaiso University in Indiana.

Advisory Board

The Nightfood advisory board includes Tom Morse, founder of 5-Hour Energy and Living Essentials, LLC.; Doron Stern, former vice president of marketing at Chobani and Popcorn, Indiana; restaurateur and celebrity Chef Chris Santos; Paul Jarrett, CEO of fast-growing nutrition startup BuluBox; Eric Egeland, president of Capacity Consulting Inc.; Dr. Michael A. Grandner, director/Sleep and Health Research Program at the University of Arizona; Dr. Michael Breus, sleep expert and best-selling author known to millions as The Sleep Doctor(TM); Dr. Lauren Broch, resident nutrition, sleep disorder expert and a member of the scientific advisory board.

Nightfood Holdings, Inc. (NGTF), closed the day's trading session at $0.66396, up 2.15%, on 232,296 volume with 101 trades. The average volume for the last 3 months is 549,516 and the stock's 52-week low/high is $0.16/$0.92.

Recent News

chart

Chemistree Technology Inc. (CSE: CHM) (OTC: CHMJF)

The QualityStocks Daily Newsletter would like to spotlight Chemistree Technology Inc. (CSE: CHM) (OTC: CHMJF).

Chemistree Technology Inc. (CSE: CHM) (OTC: CHMJF) was featured today in the 420 with CNW by CannabisNewsWire. Two separate cannabis bills have been passed by the Washington state Senate. One has to do with the use of medical cannabis in schools and another regards testing cannabis products before they get on the market.

Chemistree Technology Inc. (CSE: CHM) (OTC: CHMJF), an investment company focused on the U.S. and international cannabis sectors, provides turnkey solutions for the regulated cannabis industry. The company leverages managements' expertise and decades of experience in the cannabis industry to acquire and develop vertically integrated cannabis assets. Chemistree recently closed on a purchase of prospective cannabis cultivation property in California, made a first investment in the Canadian cannabis industry, owns assets in the State of Washington used to operate an established retail cannabis brand, and has an active pipeline of assets in place to grow its portfolio.

Chemistree offers industry leading expertise across all areas the cannabis business and in its growth as a public or private company.

  • Investment and funding for rapid growth
  • Vertical integration solutions
  • Construction, design and/or optimization of indoor or outdoor cultivation facilities
  • Reputation management & influencer outreach
  • Branding and Packaging
  • Social Media and Media outreach

With the marketing of cannabis companies and their products in its infancy, the company believes the industry offers tremendous opportunity for growth in the U.S. and abroad. Chemistree initially targeted the Pacific Northwest for investment and, following its recent California property purchase, expects to expand vertically across the United States in areas where it has a competitive business advantage.

Through its wholly owned CHM Desert LLC subsidiary, Chemistree owns 9.55 acres of undeveloped land in Desert Hot Springs, California. The property is zoned as Light Industrial Lands Designated for Marijuana Cultivation, and local zoning ordinances allow as a conditional use the location of up to three onsite cannabis cultivation buildings of 68,000 square feet each, along with support space that would support production of 55,000 pounds/year.

Through its wholly owned Chemistree Washington Ltd. subsidiary, Chemistree acquired physical assets used in the cultivation, production and distribution of cannabis. The Washington assets are currently under lease to Sugarleaf Farm LLC, which operates the Sugarleaf brand of retail cannabis products in the State of Washington. Sugarleaf Farm is a Tier 3 cannabis producer and processor whose products are sold in about 125 retail outlets. Chemistree has indicated the relationship with Sugarleaf may provide the company with additional opportunities to become involved in the marketing of Sugarleaf products.

Chemistree funded these acquisitions and investments with the proceeds of two non-brokered private placement financings completed earlier this year under the regulations of the Canadian Securities Exchange, totaling CAD$4.5 million. In conjunction with the private placements, the company was granted approval by the CSE for a change of business to become an Investment Issuer. This funding is expected to provide the company "maximum flexibility to take advantage of the numerous opportunities available in the cannabis industry in Canada and the U.S."

Chemistree also has a strategic investment in Pasha Brands Ltd., a British Columbia based cannabis company with multiple internationally recognized brands. Pasha has a proven history in cannabis retailing and its proposed Licensed Processing (LP) facility on Vancouver Island is in the final stage of the application for government approval. The LP facility is expected to assist in licensing selected craft growers of cannabis and expanding the distribution of locally grown product. The investment represents less than 10% of Chemistree's working capital.

Company Chairman Justin Chorbajian is co-owner of the largest chain of privately owned hydroponic retail shops in Canada. He also cofounded a group of companies that manufacture and distribute hydroponic equipment. He is a frequent contributor to Growing Exposed, the leading video series dedicated to cannabis cultivation. Company President Karl Kottmeier is a former investment advisor with 20 years of experience listing, financing and administering companies on the Toronto Stock Exchange and TSX Venture Exchange. He has raised more than $150 million in equity capital for ventures. Chemistree CFO Doug Ford has been general manager of Dockside Capital Group Inc., a private merchant banking and venture capital firm serving emerging growth companies. Sheldon Aberman, the most recent member of the Board, has managed, designed and created industry leading grow room designs around the world. Additionally, he has built several leading brands such as Frost Box and Black Label and is an expert in the accessory market (vape pens, silicon mats and extraction tools etc.).

Data firm Statista has forecast the U.S. legal cannabis market will be worth more than $24 billion by 2025. New Frontier Data, which focuses exclusively on the cannabis industry, projects the value of the Canadian domestic cannabis market that same year at CAD$9.2 billion.

Chemistree Technology Inc. (CHMJF), closed the day's trading session at $0.5261, up 11.04%, on 236,233 volume with 154 trades. The average volume for the last 3 months is 39,245 and the stock's 52-week low/high is $0.268/$0.605.

Recent News

chart

Petroteq Energy Inc. (TSX.V: PQE) (OTCQX: PQEFF)

The QualityStocks Daily Newsletter would like to spotlight Petroteq Energy Inc. (PQEFF).

Petroteq Energy Inc. (TSXV: PQE; OTC: PQEFF; FSE: PQCF), a fully integrated oil and gas company, is pleased to announce the execution of a definitive agreement for the acquisition of an additional 50% of the operating rights and interests relating to oil sands under U.S. federal oil and gas leases encompassing approximately 8,480 gross acres (4,240 net acres, less royalty) in the State of Utah.

Petroteq Energy Inc. (TSX.V: PQE) (OTCQX: PQEFF) is a Canadian-registered, publicly traded company engaged in the development and implementation of proprietary technologies for the environmentally safe extraction of heavy oils from oil sands, oil shale deposits and shallow oil deposits. The company is focused on oil sands exploration and production on mineral leases in Vernal, Utah, and in expanding production capacity at its Asphalt Ridge heavy oil extraction facility in Utah.

Petroteq Energy’s patent-pending application is a closed-loop, solvent-based process, which results in significantly lower per-barrel production costs than those incurred with traditional hot water-based oil sands extraction technologies. This green technology utilizes a small, modular footprint, produces no greenhouse gases, requires no high temperatures, leaves only clean dry sand, and could be deployed to unlock heavy oil deposits located around the world.

The Company’s Asphalt Ridge mineral lease on 2,500-plus acres in northeastern Utah features a large contingent oil sands resource base with an estimated 87 million barrels of oil equivalent. In 2015, the company produced 10,000 barrels of oil from the Utah location and plans to increase production are underway. Utah holds over 32 billion barrels of undeveloped oil sands resources, which are also known as “oil-wet” deposits containing a mixture of sand and a dense, extremely viscous form of petroleum referred to as bitumen or tar. A recent upswing in developing domestic energy sources has intensified interest in technological advances such as Petroteq’s Clean Oil Recovery Technology (CORT) System.

The Company continues to evaluate the development of other medium to heavy oil exploration, production and recovery projects on a global basis through a variety of structured agreements. These opportunities or other arrangements with private and governmental entities that utilize Petroteq Energy’s proprietary licensed technologies are expected to generate a significant return on investment.

The Company’s management team, board of directors and officers form an invaluable cross-section of industry leaders with extensive experience ranging from chemical engineering and solvent research, business development, international project management, entrepreneurial achievements, and senior management for global energy companies in North America and the Middle East. This impressive knowledge base covers both conventional and unconventional oil and gas projects and production, both in upstream and downstream industry sectors.

Petroteq Energy is also participating in a blockchain initiative aimed at solving the global transaction needs of the oil and gas industry through the development of PetroBLOQ. PetroBLOQ recently joined the Enterprise Ethereum Alliance (“EEA”), the world’s largest open-source blockchain initiative. Membership with the 200-member EEA represents a wide variety of industries and offers 14 industry-focused, member-driven working groups.

“Joining this community of forward-looking enterprises and blockchain innovators is an important step for PetroBLOQ as we develop transformative solutions for the oil and gas industry,” said Petroteq Energy Chairman Alex Blyumkin.

In addition, Petroteq has joined the American Petroleum Institute (API). The API is the only national trade association representing all facets of the oil and natural gas industry, promoting safety across the industry globally and influencing public policy in support of a strong, viable oil and natural gas industry.

“API has led the development of operating standards for our industry, and we look forward to contributing our experience with oilfield technologies in addition to introducing our PetroBLOQ platform to its members throughout the supply chain,” Blyumkin previously stated.

Petroteq Energy Inc. (PHVAF), closed the day's trading session at $0.303325, up 2.28%, on 380,131 volume with 119 trades. The average volume for the last 3 months is 130,533 and the stock's 52-week low/high is $0.285/$1.43.

Recent News

chart

Redfund Capital Corp. (CSE: LOAN) (OTC: PNNRF) (FF: O3X4)

The QualityStocks Daily Newsletter would like to spotlight Redfund Capital Corp. (PNNRF).

Redfund Capital Corp. (CSE: LOAN) (OTC: PNNRF) (Frankfurt: O3X4), a company focused on providing debt and equity funding in the mid-to-late stages of a target company's development or in technologies that are developed and validated by revenues, today announces the broadcast of its exclusive audio interview with NetworkNewsAudio (NNA), a NetworkNewsWire (NNW) Solution that delivers clients unparalleled visibility, recognition and brand awareness in the investment community. The interview can be heard at http://nnw.fm/gHVD3.

Redfund Capital Corp. (CSE: LOAN) (OTC: PNNRF) (FF: O3X4) is a merchant bank focused on providing debt and equity funding in the mid to late stages of a target company’s development and for technologies that are developed and validated by revenues. Redfund’s current focus is on medical cannabis, hemp and cannabidiol (CBD) related and healthcare-related companies.

As the first medical cannabis incubator and accelerator financing medical cannabis, CBD and hemp companies through a debt facility, Redfund is effectively bridging finance gaps and helping revenue-producing medical cannabis-related companies grow and build their valuations without prematurely diluting their equity.

The central components of the company’s business strategy are:

  • Establishing the foundation of a loan portfolio that generates revenues through monthly interest income from loans to cover all general and administrative expenses related to day-to-day operations.
  • Growing shareholder value by converting all or part of loans and warrants into equity in portfolio clients as clients build their valuations by entering the public markets or becoming the high-priced targets of larger entities.

Redfund was designed by bankers and entrepreneurs possessing years of experience in business, consulting, capital markets, corporate finance and healthcare services. The company is actively looking beyond borders and creating global companies that have strong fundamentals and are ready to expand.

Redfund’s investments are deployed to companies that have demonstrated success in their business but need a capital bridge in order to expand. Redfund’s team of professionals vet every project and analyzes each prospective client’s financials and business plans. Once a project is approved, Redfund’s legal team carefully scrutinizes the collateral used to securitize the individual loans.

The strategy employed by Redfund includes:

  • Diversifying investments in Canada and other countries
  • Building an international footprint with established national leaders
  • Funding new drug delivery systems and helping nutraceuticals become mainstream drugs
  • Introducing companies to Canada as a viable option for public listings
  • Becoming a premier go-to lender for established companies

The company’s revenue sources include:

  • Interest-bearing debt instruments with asset-backed collateral to securitize loans
  • Equity kicker of warrants coverage on original loan
  • Conversion ability of loan in its entirety
  • Advisory fees from contracts for consulting on growth strategies
  • Right of first refusal on future financing in each company funded

Redfund Capital Corp. (PNNRF), closed the day's trading session at $0.16, even for the day. The average volume for the last 3 months is 425 and the stock's 52-week low/high is $0.10/$0.505.

Recent News

chart

Wildflower Brands Inc. (CSE: SUN) (OTCQB: WLDFF)

The QualityStocks Daily Newsletter would like to spotlight Wildflower Brands Inc. (WLDFF).

Vancouver-based Wildflower Brands Inc. (CSE: SUN) (OTCQB: WLDFF) today announced that it has signed an agreement with Two Towers to expand the Wildflower Wellness brand's CBD+ line of products into Poland. To view the full press release, visit http://nnw.fm/IIa9E.

Wildflower Brands Inc. (CSE: SUN) (OTCQB: WLDFF) is a public cannabis company developing and designing brands that focus on plant-based wellness and health products. Wildflower markets its full-spectrum CBD products to retailers in the health and wellness space throughout the United States and in legal cannabis markets in accordance with regulations marketing its THC and CBD products.

Headquartered in Vancouver, British Columbia, Canada, Wildflower employs a unique and holistic business model that encompasses research and development, manufacturing, distribution, marketing and retail. First launched in 2012 as a private company with a cannabis-focused brand, Wildflower went public in 2014 and has since reached numerous significant milestones in its drive to create brands that work in synergy toward becoming a global wellness brand leader.

Gathered within the growing family of Wildflower brands are the following entities:

  • Wildflower Wellness is known for its reputable brand, uncompromising quality and mission to connect people with the healing power of plants. Wildflower Wellness offers CBD vaporizers, capsules, tinctures, soaps and topicals that are backed by a 100 percent satisfaction guarantee. Wildflower Wellness offers a full lineup of full spectrum CBD extract infused products made in the U.S. in Wildflower’s GMP facilities which are always third-party lab tested for quality assurance and accurate labeling.
  • King Extracts is a California-based company focused on cannabis technology and delivery systems. The King Recharge is a discreet, 97mm small, rechargeable vaporizer with a sleek pocket-sized charging and storage case. King concentrates are clean and sophisticated blends made from CO2 extractions that are fractionally distilled for clarity and purity with proprietary terpenes blended in to deliver a robust, full-flavor profile. King products are available at 26 select, regulated retail dispensaries in California.
  • Exclusive is a dispensary of high-quality cannabis products and accessories serving the city of Los Angeles, California. The company enjoys a close association with select hospital oncology departments and community programs.

Using the slogan “Plants Heal,” Wildflower’s distribution network in the U.S. includes 200+ retailers in Washington state and 20+ retailers in New York City. Wildflower has also partnered with Retail Worx to establish shop-in-shop retail locations in the heart of New York City which pairs nicely with the introduction of Wildflower into existing Bridges General’s stores in New York City and San Francisco. Through this partnership with Retail Worx, Wildflower by Bridges General stores will have exclusive product offerings in addition to the full lineup of existing Wildflower Wellness CBD products. Distribution in other U.S. markets includes 80+ wellness and healthcare practitioners with a total distribution of over 300 stores nationwide.

Wildflower holds 14 California cannabis licenses that cover recreational and medical cannabis cultivation, manufacturing, distribution and retail/delivery in the jurisdictions of California state and the city of Los Angeles. Opportunities to activate these licenses creates the phenomenal potential of driving significant revenues while minimizing risk. Expansion plans into Canada are underway with discussions centered on retail acquisitions and Wildflower launching into over-the-counter market with its CBD product line. Global expansion is a key part of Wildflower’s strategy with initial plans aimed at specific international markets where regulatory hurdles are less restrictive.

In December 2018, Wildflower began on-demand, legal and licensed cannabis delivery services to adult consumers in the Los Angeles area and has hired dozens of full-time delivery drivers to accommodate this unmet need. Wildflower has partnered with leading technology and logistics company Eaze.com to help route deliveries efficiently, manage inventory and comply with California law. Providing legal, licensed delivery services helps to ensure that all adults including those with mobility challenges and limited access to transportation services can purchase high quality, legal cannabis products.

Wildflower’s direct-to-consumer online store sales have shown an organic growth. The Company recently achieved over 300 percent growth in online sales since January 2018 with annualized revenues exceeding $1 million for online sales only, marking the ninth consecutive quarter of increased revenue.

Core Team

William MacLean is the founder and CEO of Wildflower Brands Inc. His involvement in all aspects of the business from product R&D to manufacturing setup has led the Company to its current success. MacLean is a seasoned sales professional with over 20 years of experience in various industries from advertising and marketing to medical sales. While in the advertising and marketing space, his clients included major brands including: Bell, Remax, BC Hydro, and Royal Bank.

CFO Stephen Pearce is a director and officer of a number of public companies in the resource sector. His professional experience as a practicing attorney is primarily in corporate and securities work. Pearce’s academic background includes an honors bachelor’s degree in economics from York University, in which he focused specifically on corporate finance. Pearce obtained a law degree from the University of British Columbia.

Alfred Kee, COO, is a business technology leader with over 15 years of experience in building high performing teams at small startups to large enterprises. With foundations in running large scale business critical technology and user experience product management mindset, Kee excels at guiding teams to deliver business value with agility. His knowledge and experience were honed while working with Electronic Arts, KPMG, CenturyLink, Cisco and Apple, as well as a string of successful startups. Lee brings a global perspective having lived and worked through parts of the U.S., Canada, Europe and Asia.

Creative Director Amy Yamamura is a founding member of Wildflower and has been a driving force behind the Company from the start, creating the Wildflower brand. After receiving a bachelor’s degree in communications from Boston University, Yamamura returned to Tokyo to develop her career in TV as an international business correspondent coordinating collaborative projects between top creators around the world and corporations. Yamamura’s unique experience in working closely with successful Japanese brands like UNIQLO has given her exceptional eyes for branding a company.

Wildflower Brands Inc. (WLDFF), closed the day's trading session at $0.567, off by 0.12%, on 5,114 volume with 12 trades. The average volume for the last 3 months is 21,454 and the stock's 52-week low/high is $0.009/$1.139.

Recent News

chart

QMC Quantum Minerals Corp. (OTC: QMCQF) (TSX-V: QMC) (FSE: 3LQ)

The QualityStocks Daily Newsletter would like to spotlight QMC Quantum Minerals Corp. (QMCQF).

British Columbia-based company Quantum Minerals (OTC: QMCQF) (TSX.V: QMC) (FSE: 3LQ) this morning provided an update on its Irgon Lithium Mine Project located within the prolific Cat Lake-Winnipeg River rare-element pegmatite field of S.E. Manitoba. To view the full press release, visit: http://nnw.fm/Q2Ai4.

QMC Quantum Minerals Corp. (OTC: QMCQF) (TSX-V: QMC) (FSE: 3LQ) is a British Columbia based company engaged in the business of acquisition, exploration and development of natural resource properties. QMC’s focus is on creating shareholder value through strategic acquisition and development of high quality lithium, silver, gold, nickel, copper and zinc prospects.

QMC’s current properties are in the Canadian province of Manitoba, one of Canada’s most productive, centrally located mining regions. These resources include the Irgon Lithium Mine project and two Volcanic Massive Sulphide (“VMS”) properties – the Rocky Lake and Rocky-Namew known collectively as the Namew Lake District Project – which contain base metal-rich mineral deposits. Excellent access and well-developed mining infrastructure to the company’s wholly-owned Irgon Lithium Mine Project offers significant value and ramps up the near-term production schedule, putting QMC in a position to take advantage of rising lithium prices.

The region’s historic resource estimate of lithium is well documented in a 1956 Assessment Report developed by a previous owner, Lithium Corporation of Canada Ltd. The project’s historical resource estimate of 1.2 million tons grading 1.51% lithium-oxide over a strike length of 365 meters and to a depth of 213 meters is being updated by QMC through a detailed channel sampling and subsequent drill program.

North Face Software Ltd. recently created an interactive 3-D model of the Irgon Dike utilizing all historical data derived from past drilling and underground work. The 3-D model clearly demonstrates that exploration and underground development has only taken place on the central portion of the dike, leaving significant potential to quickly increase tonnage.

The company’s latest assay results, obtained from 144 channel samples at QMC’s Irgon Lithium Mine Project, provided encouraging and positive results that compare favorably with the historic assays. QMC has received a drill permit from the Sustainable Development Office of the Manitoba government and is in the process of requesting and assessing bids from drilling contractors. The company plans to begin a 2,000-meter drill program to confirm the historic lithium oxide assay results documented in the historic 1953-54 drill program.

QMC’s experienced leadership team includes specialists in mineral exploration, geology, engineering, new business development, marketing and investor relations. The company’s team of qualified advisors includes consultant Bruce E. Goad, P.Geo., who has 40 years of experience in mineral exploration in Canada, Argentina, Asia and Africa. As a Qualified Person, Goad has worked on numerous deposit styles including rare element pegmatites, porphyry, banded iron formation (BIF) gold deposits, skarn, greisens,  and VMS. He has a wide and varied skill set which includes precious, base, industrial and rare metal projects with a sharp focus on gold exploration. Goad is the author of several scholarly publications on pegmatite granites of the southeastern Manitoba region.

The market for lithium has surged over the past three years with prices per metric ton tripling. The world’s rising demand for portable power can easily been seen in the electric vehicle and mobile device industries – both of which use lithium-based, renewable batteries as a power resource. QMC’s high potential prospects and experienced management team, both in geology and corporate finance, put QMC and its shareholders in an excellent position to take advantage of the lithium, precious and base metals markets.

QMC Quantum Minerals Corp. (QMCQF), closed the day's trading session at $0.191, pff by 6.37%, on 49,810 volume with 17 trades. The average volume for the last 3 months is 54,798 and the stock's 52-week low/high is $0.1155/$0.5122.

Recent News

chart

Sugarmade, Inc. (SGMD)

The QualityStocks Daily Newsletter would like to spotlight Sugarmade, Inc. (SGMD).

Hydroponic agriculture supplier Sugarmade Inc. (OTCQB: SGMD) is preparing to significantly expand its operations in the hemp cultivation industry following recent regulatory changes in the agriculture sector and a new agreement with Kentucky-based hemp cultivator Hempistry Inc. to deliver resources for its plant micropropagation work.

Sugarmade, Inc. (SGMD), one of the largest publicly traded hydroponics supply companies moving into the industrial hemp space, is a product and brand marketing company investing in products and brands with disruptive potential. Sugarmade’s brands include: ZenHydro.com; CarryOutSupplies.com; and BudLife. Headquartered in Monrovia, California, a city within Los Angeles county, Sugarmade has various business operations in diverse marketplaces including packaging and paper goods for various industries, agricultural supplies.

Sugarmade has expanded into the European hydroponics supply market with a growing base of orders taken through Amazon UK. Over the past few financial quarters, Sugarmade has seen revenue growth patterns expand geographically. As recently as mid-2017, the majority of hydroponic-related revenue growth was seen from California and other West Coast marketplaces, however growth is becoming more geographically dispersed among U.S. states where legalization has eased restriction. This movement into the United Kingdom further expands the base of geographic growth areas for Sugarmade.

Sugarmade recently launched a new corporate initiative in the booming industrial hemp and CBD, committing up to $1 million in capital over the next 12 months to invest in Hempistry, Inc., a privately held Nevada corporation. Hempistry has begun planting an ultra-high cannabidiol (CBD) industrial hemp strain on a land option it holds on 23,000 acres of prime Kentucky farmland. The strain of industrial hemp being grown by Hempistry is ultra-rich in CBD but contains less than 0.3 percent of THC, the psychoactive ingredient found in cannabis. The U.S. hemp industry is expected to produce well over $1 billion in revenues in 2018, with a compound annual growth rate of 14 percent through 2022, according to the Hemp Business Journal.

Demand for industrial hemp and products derived from hemp is soaring, with no let-up in sight, which the company sees as a “tremendous opportunity to become a supplier to this fast-growing sector,” said Chairman and CEO Jimmy Chan, who is also an advisor and minority shareholder of Hempistry.

Sugarmade’s investment into the market for high-CBD hemp is expected to be highly accretive for common shareholders in two ways. First, Sugarmade’s investment will be in the form of common shares in Hempistry allowing Sugarmade common shareholders to possibly benefit from any future initial public offering of Hempistry. Second, Sugarmade is expected to sign a supply agreement with Hempistry for cultivation supplies, which would be additive to corporate revenues.

Sugarmade has also completed a master market agreement with industry leader BizRight Hydroponics, Inc., a leading marketer and manufacturer of cannabis and hydroponic growth supplies, which offers a range of hydroponics-related products including: HPS grow lights, electronic ballasts, HPS bulbs, nutrient mixes, environmental control products, pH measurement and calibration solutions and storage products. BizRight operates the ZenHydro.com website and other e-commerce properties and sells various products to distributors and retailers. BizRight is expected to produce in excess of $30 million in revenues during 2017, with substantial growth expected for 2018.

Sugarmade division CarryOutSupplies.com, the leader in paper and plastic take-out supplies, serves nationwide customers by offering a wide array of high quality products that are cost-efficient, custom-made and delivered on time. This business unit currently serves 2,000 quick service restaurants, garnering from 30-40 percent of the market share. Sugarmade plans to expand operations via the addition of market share and the introduction of new product offerings.

Management

CEO Jimmy Chan is an experienced business executive instrumental in growing multiple business operations with a strong expertise in international trade and banking, and international manufacturing and importation. He is also the founder of CarryOutSupplies.com, a company that revolutionized the custom-printed paper supplies subsector of the quick service restaurant industry, which merged with Sugarmade in 2014.

Arman Tabatabaei serves as operations consultant, providing high-level, day-to-day strategic guidance and tactical operational supervision for all aspects of the corporation’s business. He is an expert at data collection and analysis relative to resource management, risk forecasting and profit and loss management.

Sugarmade specializes in growing and acquiring innovative brands to maximize value for company employees, shareholders and other stakeholders. Sugarmade believes its future is very bright as the company expands operations within the cultivation sector and rapidly increases its revenue base. 6

Sugarmade, Inc. (SGMD), closed the day's trading session at $0.049715, off by 1.75%, on 686,937 volume with 66 trades. The average volume for the last 3 months is 1,285,766 and the stock's 52-week low/high is $0.0425/$0.209.

Recent News

chart

Marijuana Company of America Inc. (MCOA)

The QualityStocks Daily Newsletter would like to spotlight Marijuana Company of America Inc. (MCOA).

Marijuana Company of America Inc. (MCOA) was highlighted today in a publication from Financialnewsmedia.com, examining how U.S. & Canadian cannabis companies are both getting ready to beat the other in a 21st century  'gold rush' to the south… one that the U.S. should eventually win due to a larger domestic consumer base.

Marijuana Company of America Inc. (OTC: MCOA) (the "Company") are pioneers in the cannabis industry going back to 2009 when Don Steinberg, MCOA’s CEO, founded the first marijuana company ever to trade on a U.S. stock market, Medical Marijuana Inc. Since then, Don and his partner, Charlie Larsen, have formed Global Hemp Group and Marijuana Company of America. They have experienced the shift of legislation first hand, not only for the legalization of marijuana but also the emerging hemp-based CBD products.

The CBD market is growing exponentially and consequently the founders of MCOA have constructed their business model around the development of industrial hemp-based CBD products. The industrial hemp plant can be used to produce products that are carbon neutral or even carbon negative. It is one of the longest, strongest natural fibers on earth, used as a building material that is free of mold, pesticide-resistant, and fire proof. Hemp has also been described as a “super food,” which provides additional business opportunities. No part of the plant is left unused and the Company’s overall strategy is to take advantage of every profit center from farm to the multiple valuable finished products.

The cannabis and hemp industries are experiencing unprecedented growth that is expected to continue for many years as these industries are now accepted globally and continue to mature and expand. North American consumers spent $6.7 billion on legal cannabis products in 2016, up 34% from 2015’s $5 billion. This trend is widely expected to explode at a 27% compounded annual growth rate to reach $22.6 billion by 2021, according to ArcView Market Research.

The company offers investors the opportunity to be on the forefront of cannabis and hemp innovation through cultivation, processing in the legal cannabis and industrial hemp sectors. The Company’s business model includes producing a diverse portfolio of synergistic business segments that provide value to its shareholders. Its vertically integrated business model and distribution platforms are positioned to capture market share by developing recognizable and valuable brands.

Under the MCOA umbrella, wholly owned subsidiary hempSMART™, Inc. is committed to bringing high quality CBD-based products to the market through its affiliate marketing program. Through hempSMART, MCOA’s strategic approach to the distribution of products is through a networking architecture geared to maintain customer loyalty and capture market share. The patent-pending product “hempSMART Brain,” is designed to revolutionize the safe and effective support of healthy brain function. The brand new product, HempSMART DROPS, is a full-spectrum CBD tincture formulated with hemp and fractionated coconut oils. The hempSMART marketing team has decades of experience, and is well positioned to take the hempSMART brand to a global audience.

Marijuana Company of America Inc. (MCOA), closed the day's trading session at $0.0137, off by 3.52%, on 11,408,329 volume with 345 trades. The average volume for the last 3 months is 11,414,195 and the stock's 52-week low/high is $0.01025/$0.0499.

Recent News

chart

The QualityStocks Numbers Report

By The Numbers Chart

Top Performers


QualityStocksTwits

QualityStocksTwits is your stock tracking service portal to Twitter's universe of stock picks, commentary and research.

Visit Portal


The QualityStocks Sponsored News


The QualityStocks DailyNetwork Sponsors

ActionStockPicksAgressive StocksBetting On Wall StreetCannabisNewsWireGot Stocks?Got Stock Tips?Green Car StocksGreen Energy StocksGreen On The StreetHomeRunStocksMissionIRMissionIR MediaMissionPRMissionSMRNetworkNewsWireQualityStocks MediaQStocksQualityStocksQualityStocks TwitsSeriousTradersSmallCapRelationsSocial Media RelationsStock BeatsStocks To Buy NowTerrificStocksTiny GemsTip.usTouchdownStocksDaily ToutTraderPower

About The QualityStocks Daily

The QualityStocks Daily Newsletter brings you the latest company News and Profiles featuring the "Top Movers and Shakers" from the Small Cap Market each trading day. QualityStocks is committed to bring our subscribers Public companies in our Newsletter Section "Free of Charge" based on Percentage gained, Momentum, Press, and or Company Fundamentals.

Why do we spotlight companies for Free?
We Want To bring our subscribers the top movers in an unbiased setting.

"Homework Eliminates Mistakes"
Please never invest in a company anyone profiles unless you do the proper research and due diligence.

QualityStocks is compensated by the companies in The QS Company Corner. These companies will include a disclaimer with the amount and term of compensation.

Please consult the QualityStocks Market Basics Section on our site.